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ABSTRACT 
 
Cancer is considered to be a very atrocious disease since the time man started 
to imagine about therapeutics. It is one of the leading causes of morbidity and 
mortality worldwide. The majority of world’s population in developing countries still 
relies on herbal medicine to meet their health needs. The impact of toxicity/ ADR of 
the synthetic anticancer drug also paved the way for the focus on herbal medicines. 
Azima tetracantha Lam., is belonging to the family Salvadoraceae used in the Folk 
medicine to treat various ailments. In the present work, the various extracts of leaves 
and stem of Azima tetracantha were subjected to pharmacognostical, phytochemical 
and pharmacological studies. The plant extracts were evaluated for in vitro anticancer 
activity against MCF-7 cell lines using MTT assay. Based on MTT assay, the active 
extract was subjected to bioactivity guided isolation by column chromatography using 
hexane, chloroform and ethanol. All the fractions and isolated compounds were 
evaluated for their invitro antioxidant activity and the compound that showed high 
antioxidant effect on DPPH further evaluated for invivo acute toxicity studies and 
spectral studies. From all the fractions tested, the more effecient fraction (IBC32) 
subjected to invitro anticancer activity on various cell lines (MCF-7, HeLa and A549) 
using MTT assay. Docking studies were carried out for the isolated bioactive 
compound (IBC32) with various targeting enzymes such as PDB ID- 4O33, 2Y3I, 
3UEN and 3ZOZ.  
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CHAPTER 1 
INTRODUCTION 
 Cancer is an uncontrolled growth of cells, with loss of differentiation 
and commonly with metastasis, spread of the cancer to other tissues and organs.1,2 
Cancer is a genetic disease as it can be traced for alteration within specific genes, but in 
most cases, it is not an inherited disease. The genetic alterations that lead to most 
cancers arise in the deoxyribonucleic acid (DNA) of somatic cell. Because of these 
genetic changes, cancer cells proliferate uncontrollably, producing malignant tumour 
that invade the surrounding healthy tissues.3,4 
Cancer is also called as Neoplasia which literally means “new growth”. The 
new growth produced is called ‘neoplasm’ or ‘tumour’. Neoplastic cells are said to be 
transformed because they continue to replicate, apparently oblivious to the regulatory 
influences that control normal growth. Therefore, satisfactory definition of a neoplasm 
or tumour is ‘a mass of tissue formed as a result of abnormal, excessive, 
uncoordinated, autonomous and purposeless proliferation of cells even after cessation 
of stimulus for growth which caused it’. The study of tumours is called oncology (from 
oncos, “tumour”, and logos, “study of”).5-7 
Neoplasm may be benign when they are slow growing and localized without 
causing much difficulty to the host or malignant when they proliferate rapidly, spread 
throughout the body and may eventually cause death of the host. 4,5 
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1.1. HISTORY 
Hippocrates (460-377 BC) coined the term karkinos for cancer of the breast. 
The word ‘cancer’ means crab, thus reflecting the true character of cancer since ‘it 
sticks to the part stubbornly like a crab’.8 This name comes from the appearance of the 
cut surface of a solid malignant tumor, with "the veins stretched on all sides as the 
animal the crab has its feet, hence it derives its name".9 Galen stated that "cancer of the 
breast is so called because of the fancied resemblance to a crab given by the lateral 
prolongations of the tumor and the adjacent distended veins".10 
Old theories about cancer11 
Humoral theory 
Hippocrates believed that the body contained 4 humors (body fluids) such as 
blood, phlegm, yellow bile and black bile. Any imbalance of these fluids will result in 
disease and excess of black bile in a particular organ site was thought to cause cancer. 
This theory of cancer was standard through the Middle Ages for over 1300 years.  
Lymph theory 
This theory proposed that cancer formation by fluid called lymph. Life was 
believed to consist of continuous movement of the fluids like as blood and lymph in the 
body. The lymph theory was supported in 17th century that tumors grow from lymph 
constantly thrown out by the blood. 
Blastema theory 
Muller demonstrated that cancer is made up of cells but not with lymph in 1838. 
Virchow (1821-1902) determined that all cells including cancer cells were derived from 
other cells. 
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Chronic irritation theory 
Virchow proposed that chronic irritation was the cause of cancer. Later Thiersch 
was showed that cancers metastasize through the spread of malignant cells and not 
through some unidentified fluid. 
 
Trauma theory 
From the late 1800s until the 1920s, cancer was thought to be caused by trauma. 
 
Parasite theory 
Till 18th century, scientists believed that cancer was contagious and spreads 
through parasite. 
 
1.2. EPIDEMIOLOGY 
 Worldwide, it is estimated that about 20% of all deaths are cancer-related; in 
US, cancer is the second most common cause of deaths, next to heart disease.5,6 In 
2008, approximately 12.7 million cancers were diagnosed (excluding non-melanoma 
skin cancers and other non-invasive cancers),12 and in 2010 nearly 7.98 million people 
died.13 Cancers as a group account for approximately 13% of all deaths each year with 
the most common being: lung cancer (1.4 million deaths), stomach cancer (740,000 
deaths), liver cancer (700,000 deaths), colorectal cancer (610,000 deaths), and breast 
cancer (460,000 deaths).14 This makes invasive cancer the leading cause of death in the 
developed world and the second leading cause of death in the developing world.             
Table 1 showed worldwide incidence of different forms of cancer in men, women and 
children. 
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Table 1: Five most common primary cancers in the world 
S. No Men Women Children 
1. Lung (Oral cavity in India) Breast (Cervix in India) Acute leukemia 
2. Prostate Lung CNS tumour 
3. Colorectal Colorectal Bone sarcoma 
4. Urinary bladder Endometrial Endocrine 
5. Lymphoma Lymphoma Soft tissue sarcoma 
 
1.3. TYPES OF CANCER15,16 
Cancers are classified by the type of cell that the tumor cells resemble and are 
therefore presumed to be the origin of the tumor. These types include: 
 Carcinoma: Cancers derived from epithelial cells. This group includes many of 
the most common cancers, particularly in the aged, and include nearly all those 
developing in the breast, prostate, lung, pancreas and colon. 
 Sarcoma: Cancers arising from connective tissue (i.e. bone, cartilage, fat, 
nerve), each of which develops from cells originating in mesenchymal cells 
outside the bone marrow. 
 Lymphoma and Leukemia: These two classes of cancer arise from 
hematopoietic (blood-forming) cells that leave the marrow and tend to mature in 
the lymph nodes and blood, respectively. Leukemia is the most common type of 
cancer in children accounting for about 30%.17 
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 Germ cell tumor: Cancers derived from pluripotent cells, most often presenting 
in the testicle or the ovary (seminoma and dysgerminoma, respectively). 
 Blastoma: Cancers derived from immature "precursor" cells or embryonic 
tissue. Blastomas are more common in children than in older adults. 
1.4. PRODUCTION OF CANCER CELL 
 Cancer is when abnormal cells divide in an uncontrolled way. Some cancers 
may eventually spread into other tissues. Cancer grows as cells multiply over and over. 
Cancer starts when gene changes make one cell or a few cells begin to grow and 
multiply too much. This may cause a growth called a tumour. A primary tumour is the 
name for where a cancer starts. Cancer can sometimes spread to other parts of the body 
is called as secondary tumour or metastasis.18 Cancer is a broad term for a class of 
diseases characterized by abnormal cells that grow and invade healthy cells in the 
body.19 
 Cancer develops when normal cells in a particular part of the body begin to 
grow out of control. There are different types of cancers; all types of cancer cells 
continue to grow, divide and re-divide.20 
 
Fig 1: Production of cancer cell 
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Global comparison shows that India has high incidence rates of cancers of oral 
cavity, pharynx & cervix. The age standardized cancer incidence in Indian registries as 
compared to incidence in certain developed countries is about half to one third in men 
and about half in women.21 
Pathophysiology of cancer 
Genetics 
Cancer is fundamentally a disease of tissue growth regulation failure. In order 
for a normal cell to transform into a cancer cell, the genes that regulate cell growth and 
differentiation must be altered.22 
The affected genes are divided into two broad categories. Oncogenes are genes 
that promote cell growth and reproduction. Tumor suppressor genes are genes that 
inhibit cell division and survival. Malignant transformation can occur through the 
formation of novel oncogenes, the inappropriate over-expression of normal oncogenes, 
or by the under-expression or disabling of tumor suppressor genes. Typically, changes 
in many genes are required to transform a normal cell into a cancer cell.23 
Genetic changes can occur at different levels and by different mechanisms. The 
gain or loss of an entire chromosome can occur through errors in mitosis. More 
common are mutations, which are changes in the nucleotide sequence of genomic 
DNA. Figure 2 showed the pathophysiology of cancer.  
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Fig 2: Pathophysiology of cancer: Cancers are caused by a series of mutations. 
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Carcinogenesis: Molecular basis of Cancer5,6 
 Carcinogenesis or oncogenesis or tumorigenesis means mechanism of induction 
of tumours (pathogenesis of cancer); agents which can induce tumours are called 
carcinogen (etiology of cancer).  
 
Fig 3: Molecular basis of cancer 
The fundamental principles involved in the molecular basis of cancers are: 
 Non-lethal genetic damage lies at the heart of carcinogenesis. Such genetic 
damage may be acquired by the action of environmental agents, such as 
chemicals, radiation or viruses. 
 Four classes of normal regulatory genes- growth promoting proto 
oncogenes, growth inhibiting tumour suppressor genes, genes that regulate 
programmed cell death (i.e.) apoptosis and genes involved in DNA repair 
are the principal targets of genetic damage. 
 Oncogenes are genes that induce a transformed phenotype when expressed 
in cells.  
 Tumour suppressor genes are genes that normally prevent uncontrolled 
growth and when mutated or lost from a cell, allow the transformed 
phenotype to develop. 
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 Genes that regulate apoptosis and DNA repair may act like proto-oncogenes 
(loss of one copy is sufficient) or tumour suppressor genes (loss of both 
copies). 
Etiology of Cancer (Carcinogenic agents)5,6 
 Genetic damage lies at the heart of carcinogenesis. Three classes of 
carcinogenic agents are chemicals, radiant energy and microbial agents. Chemical and 
radiant energy causes cancer in humans and oncogenic viruses are involved in the 
pathogenesis of tumour in several animals and human.  
1.5. SIGNS AND SYMPTOMS24,25 
Cancer is a group of diseases that can cause almost any sign or symptom. The 
signs and symptoms will depend on where the cancer is, how big it is, and how much it 
affects the organs or tissues. If a cancer has spread (metastasized), signs or symptoms 
may appear in different parts of the body.  
As a cancer grows, it can begin to push on nearby organs, blood vessels and 
nerves. This pressure causes some of the signs and symptoms of cancer. If the cancer is 
in a critical area, such as certain parts of the brain, even the smallest tumor can cause 
symptoms.  
But sometimes cancer starts in places where it won’t cause any signs or 
symptoms until it has grown quite large. Cancers of the pancreas, for example, usually 
don’t cause symptoms until they grow large enough to press on nearby nerves or organs 
(this causes back or belly pain). Others may grow around the bile duct and block the 
flow of bile. This causes the eyes and skin to look yellow (jaundice). By the time a 
pancreatic cancer causes signs or symptoms like these, it’s usually in an advanced 
stage. This means it has grown and spread beyond the place it started- the pancreas. 
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Cancer may also cause symptoms like fever, extreme tiredness (fatigue), or 
weight loss. This may be because cancer cells use up much of the body’s energy 
supply, or they may release substances that change the way the body makes energy 
from food. Cancer can also cause the immune system to react in ways that produce 
these signs and symptoms. 
 
Fig 4: Signs and symptoms of cancer 
Sometimes, cancer cells release substances into the bloodstream that cause 
symptoms that are not usually linked to cancer. For example, some cancers of the 
pancreas can release substances that cause blood clots in veins of the legs. Some lung 
cancers make hormone-like substances that raise blood calcium levels. This affects 
nerves and muscles, making the person feel weak and dizzy. 
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1.6. DIAGNOSIS 
Most cancers are initially recognized either because of the appearance of signs 
or symptoms or through screening. Cancer are investigated with medical tests include,  
 Blood tests 
 X-rays  
 CT scan 
 Endoscopy 
 
Grading of cancer5,6 
 Grading and staging are the two systems to predict tumour behavior and guide 
therapy after a malignant tumour is detected. Grading is defined as the gross and 
microscopic degree of differentiation of the tumour, while staging means extent of 
spread of the tumour within the patient.  
 
Cancer may be graded grossly and microscopically. Grading is largely based on 
two important histological features: 
 Degree of anaplasia 
 Rate of growth 
 Borders proposed the system of grading for dividing squamous cell carcinoma 
into 4 grades depending upon the degree of differentiation 
 
 Grade I: Well-differentiated (less than 25% anaplastic cells) 
 Grade II: Moderately-differentiated (25-50% anaplastic cells) 
 Grade III: Moderately-differentiated (50-75% anaplastic cells) 
 Grade IV: Poorly-differentiated or anaplastic (less than 255 anaplastic cells) 
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Staging of Cancer5,6 
The extent of spread of cancer can be assessed by 3 ways- clinical examination, 
by investigations and by pathologic examination of tissue removed. Two important 
staging systems currently followed are: TNM staging and AJC staging. 
TNM staging 
 TNM (T for primary tumour, N for regional nodal involvement and M for 
distant metastases) was developed by the UICC (Union for International Cancer 
Control, Geneva). For each of the 3 components namely T, N and M, numbers are 
added to indicate the extent of involvement. 
 T0 to T4: In situ lesion to largest and most extensive primary tumour. 
 N0 to N3: No nodal involvement to widespread lymph node involvement. 
 M0 to M2: No metastasis to disseminated haemotogenous metastases. 
AJC staging 
 American Joint Committee staging divides all cancers into stage 0 to IV and 
takes into account all the 3 components of the preceding system (primary tumour, nodal 
involvement and distant metastases) in each stage.  TNM and AJC staging systems can 
be applied for staging most malignant tumours. 
 
1.7. TREATMENTS 
Malignant neoplastic diseases may be treated by various approaches:26 
 Surgery 
 Radiation therapy 
 Immunotherapy 
 Hormonal therapy 
 Chemotherapy  
 Targeted therapy 
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Surgery 
Surgery is the primary method of treatment of most isolated solid cancers and 
may play a role in palliation and prolongation of survival. It is typically an important 
part of making the definitive diagnosis and staging the tumor as biopsies are usually 
required. In localized cancer surgery typically attempts to remove the entire mass along 
with, in certain cases, the lymph nodes in the area. For some types of cancer this is all 
that is needed to eliminate the cancer.25 
Radiation therapy 
Radiation therapy involves the use of ionizing radiation in an attempt to either 
cure or improve the symptoms of cancer. It works by damaging the DNA of cancerous 
tissue leading to cellular death. To spare normal tissues (such as skin or organs, which 
radiation must pass through to treat the tumor), shaped radiation beams are aimed from 
several angles of exposure to intersect at the tumor, providing a much larger absorbed 
dose there than in the surrounding, healthy tissue. As with chemotherapy, different 
cancers respond differently to radiation therapy.27 
Immunotherapy 
A variety of therapies using immunotherapy, stimulating or helping the immune 
system to fight cancer, have come into use since 1997, and this continues to be an area 
of very active research.28 
Hormonal therapy 
The growth of some cancers can be inhibited by providing or blocking certain 
hormones. Common examples of hormone-sensitive tumors include certain types of 
breast and prostate cancers. Removing or blocking estrogen or testosterone is often an 
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important additional treatment. In certain cancers, administration of hormone agonists, 
such as progestogens may be therapeutically beneficial.29 
Chemotherapy 
Chemotherapy is the treatment of cancer with one or more cytotoxic anti-
neoplastic drugs (chemotherapeutic agents) as part of a standardized regimen. The term 
encompasses any of a large variety of different anticancer drugs, which are divided into 
broad categories such as alkylating agents and antimetabolites.30 Traditional 
chemotherapeutic agents act by killing cells that divide rapidly, one of the main 
properties of most cancer cells. 
Targeted therapy is a form of chemotherapy that targets specific molecular 
differences between cancer and normal cells. The first targeted therapies to be 
developed blocked the estrogen receptor molecule, inhibiting the growth of breast 
cancer. Another common example is the class of Bcr-Abl inhibitors, which are used to 
treat chronic myelogenous leukemia (CML).31 Currently, there are targeted therapies 
for breast cancer, multiple myeloma, lymphoma, prostate cancer, melanoma and other 
cancers.  
The efficacy of chemotherapy depends on the type of cancer and the stage. In 
combination with surgery, chemotherapy has proven useful in a number of different 
cancer types including: breast cancer, colorectal cancer, pancreatic cancer, osteogenic 
sarcoma, testicular cancer, ovarian cancer, and certain lung cancers.25 The overall 
effectiveness ranges from being curative for some cancers, such as some leukemias32,33 
to being ineffective, such as in some brain tumors,34 to being needless in others, like 
most non-melanoma skin cancers.35 The effectiveness of chemotherapy is often limited 
by toxicity to other tissues in the body. Even when it is impossible for chemotherapy to 
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provide a permanent cure, chemotherapy may be useful to reduce symptoms like pain 
or to reduce the size of an inoperable tumor in the hope that surgery will be possible in 
the future. 
Disadvantages of Cancer treatments36 
 Surgery is traumatic larger, and some parts of surgery is difficult, not valid for 
sub-clinical metastases, cannot completely eliminate the cancer cells, cancer 
cells in a certain period of time will be long. 
 Radiation therapy equipment is expensive, the treatment expense is higher. 
 Radiation therapy long period, which normally takes 1 to 2 months. 
 Radiation is more complicated, and even loss of function caused by sector. 
 Radiation treatment is not good, and cannot completely eradicate cancer cells; 
cancer cells in a certain period of time will be long. 
 No chemical drugs to kill cancer cells specifically, to kill cancer cells also kill 
normal cells, chemotherapy will shorten the survival of patients over time. 
 The tumor is not sensitive to the drug, the use of chemotherapy, no clinical 
value.  
 Chemotherapy cannot completely kill all the cancer cells in vivo, in a certain 
time, cancer will relapse or metastasis. 
 
1.8. HERBS AND CANCER 
 For the treatment of all possible measures are being tried and still worldwide 
search is going on to explore the antineoplastic agents from various sources. Since the 
allopathic system of medicine (chemotherapy, radiation, surgery etc.,) may cause 
several unwanted side effects on the normal host tissue. The indigenous system of 
medicine has become popular throughout the world in the field of oncology. The 
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medicinal plants play a major role in the life of human and animals. These serve not 
only as a medicinal source, but also maintain the health and vitality of individuals, and 
may cure various diseases including cancer without causing any toxicity. 
Phytotherapeutic Approach 
 A phytotherapeutic approach is more useful in our condition in the search for 
anticancer drugs. In this approach, the emphasis is on the development of a new drug or 
biologically active substance whose extraction and isolation has emanated on the basis 
of anticancer activity.  
Natural products and defense against Carcinogenesis 
 The role of natural products as a source for remedies has been recognized since 
ancient times.37 There are some examples of agents derived from natural sources that 
are currently used in clinical practice.38 Paclitaxel was originally isolated from the bark 
of the yew tree Taxus brevifolia,39 a finite source of a compound. Approximately 60% 
of approved drugs of chemotherapeutic agents are derived from natural compounds.37 
Herbs that promote a healthy liver function include dandelion (Taraxacum), milk thistle 
(Silybum) and artichoke (Cynara). Camptothecin (from Camptotheca acuminata) 
inhibits the action of topoisomerase I, resulting in cell death. Another prominent 
molecule is podophyllotoxin, which has been synthetically modified into etoposide and 
is used to treat lung and testes cancer.  
Other important molecules include vincristine, vinblastine, colchicine, 
ellipticine, flavopiridol (a chromone alkaloid from Rohitukine) and a pyridoindole 
alkaloid (from Ochrosia spp). 40 The incidence of cancer can thus be substantially 
reduced by diet modification. Diets rich in vegetables, fruits and legumes contain large 
quantities of antioxidants that protect against the deleterious action of free radicals 
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which may lead to cancer development. It has been shown that synthetic cancer drugs 
cause nonspecific killing of cells, natural products offer protective and therapeutic 
actions to all cells with low toxicity. 
Advantages41 
There are number of advantages associated with herbal medicines as opposed to 
synthetic drugs. Examples include the following: 
 Reduced risk of side effects: Most herbal medicines are well tolerated by the 
patient, with fewer unintended consequences than synthetic drugs.  
 Regulation of acid-base balance: Acid-base balance by regulating the body 
fluids, improving physical fitness, so that cancer cells do not survive, can 
completely control the soaring cancer cells, so that no recurrence and metastasis 
of cancer cells. 
 Effectives with chronic conditions: Herbal medicines tend to be more effective 
for long   standing health complaints that don't respond well to synthetic drugs. 
 Cost effective: Herbs cost much less than synthetic drugs. Research, testing, and 
marketing add considerably to the cost of synthetic drugs. Herbs tend to be 
inexpensive compared to drugs. 
 Widespread availability: Herbs are available without a prescription. In some 
remote parts of the world, herbs may be the only treatment available to the 
majority of people. 
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Chemical groups of natural products with anticancer properties26 
 Plant derived natural products with documented anticancer and antitumor 
properties can be classified into the following chemical groups (Kintzios and Barberaki, 
2004):  
Table 2: Natural products containing chemical groups with anticancer properties 
Aldehydes 
Cinnamomum cassia, Mondia whitei, Rhus vulgaris, Sclerocarya caffra 
Alkaloids 
Aconitum napellus, Acronychia baueri, A. halophylla, Brucea 
antidysenterica, Calycodendron milnei, Cassia leptophylla, 
Chamaecyparis sp., Chelidonium autumnale, Ervatamia microphylla, 
Eurycoma longifolia,  
Flavonoids 
Acrougehia porteri, Angelica keiskei, Annona densicoma, A. reticulate, 
Claopodium crispifolium, Eupatorium altissimum, Glycyrrhiza inflate, 
Gossypium indicum, Polytrichum obioense, Psorospermum febrifigum, 
Rhus succedanea, Zieridium pseudobtusifolium 
Glycosides 
Phlomis armeniaca, Phyllanthus sp., Plumeria rubra (iridoids), 
Scutellaria salviifolia, Wikstroemia indica 
Lignans 
Brucea sp., Juniperus virginiana, Magnolia officinalis, Plumeria sp., 
Wikstroemia foetida 
Lipids Nigella sativa, Sho-saiko-to, luzen-taiho-to 
Quinones 
Kigelia pinnata, Koelreuteria henryi, Landsburgia quercifolia, Mallotus 
japonicas, Nigella sativa, Rubia cordifolia, Sargassum tortile, 
Wikstroemia indica 
Phenols and 
derivatives 
Acronychia laurifolia, Angelica gigas, A. decursiva, A. keiskei, 
Gossypium indicum 
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Although many plants are used to treat tumours in Indian system of medicine, 
most of these plants are not scientifically validated. A systemic and intensive ethno 
pharmacological study is carried on one or more plants used in traditional system are 
sure to provide effective anticancer drugs. For the present study, the plant Azima 
tetracantha Lam., claimed to possess anticancer activity was selected for the research. 
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CHAPTER 2 
LITERATURE REVIEW 
The aim of the literature survey is to establish a complete knowledge, based 
upon various pharmacological approaches attempted in the plant. The survey also 
aimed to understand the pharmacognosy and phytochemistry for the selection of plant. 
Thus, a detailed literature survey was carried out based on pharmacognostical, 
phytochemical and pharmacological aspect. 
2.1. BASED ON PHARMACOGNOSY 
1. Balakrishnan M et al., 42 (2010) reported the studies on pharmacognostical 
specifications of Azima tetracacntha Lam. 
2.2. BASED ON PHYTOCHEMISTRY 
2. Vinoth B and Manivasagaperumal R, 43 (2015) reported the phytochemical 
analysis of Azima tetracantha of various leaf extracts revealed that the 
presence of alkaloids, phenol, protein and flavonoids, glycosides, tannins, 
saponins, steroids and terpenoids. 
3. Gowthami M et al., 44 (2012) reported the separation of phytocompounds 
such as alkaloids, flavonoids and sterols from leaf extracts of Azima 
tetracacntha. 
4. Muthuswamy P et al., 45 (2012) performed the preliminary phytochemical 
screening and physicochemical constants of leaf extracts of Azima tetracantha.  
5. Gayathri G et al., 46 (2012) evaluated the bioactive compounds present in the 
methanolic leaf extracts of Azima tetracantha using Gas chromatography- 
Mass spectroscopy method. 
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6. Bennett RN et al., 47 (2004) reported profiling glucosinolates, flavonoids, 
alkaloids, and other secondary metabolites in tissues of Azima tetracantha 
Lam.(Salvadoraceae). They also found some dimeric piperidine alkaloids like 
azimine, azcarpine, and carpaine in all tissues of A. tetracantha. 
7. Abirami H et al., 48 (2015) identified 47 chemical constituents from the 
hexane extracts of Azima tetracantha by GC-MS analysis and concluded that, 
it is mainly composed of terpenoids and sterols. 
2.3. BASED ON PHARMACOLOGY 
8. Vinoth B and Manivasagaperumal R, 43 (2015) studied different extracts of 
Azima tetracantha root against human pathogenic bacterial and fungal strains 
using disc diffusion method.  
9. Vinoth B et al., 49 (2014) carried out in-vitro antimicrobial activity of Azima 
tetracantha leaves against various human bacterial and fungal pathogens using 
disc diffusion method.  
10. Gowthami M et al., 44 (2012) evaluated the antibacterial activity of 
phytocompound separation from alkaloids, flavonoids and sterol were tested 
against Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, 
Pseudomonas aeruginosa and Escherichia coli. Maximum zone of inhibition 
was observed in sterol compound when compared with alkaloids and 
flavonoids.  
11. Hema TA et al., 50 (2012) reported the antimicrobial effect of leaves of Azima 
tetracantha against the clinical pathogens by using agar well diffusion 
method.  
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12. Gayathri G et al., 51 (2011) proved that the methanolic extract of A.tetracantha 
leaves showed greater antimicrobial activity than chloroform extract.  
13. Duraipandiyan V et al., 52 (2010) evaluated the antifungal activity of Azima 
tetracantha extracts and its isolated compound (friedelin) against fungi using 
micro dilution method. 
14. Maruthi TE et al., 53 (2010) evaluated the anthelmintic and antimicrobial 
activities of Azima tetracantha. The results revealed that, the alcoholic extract 
was found to possess antibacterial and antifungal activities while chloroform 
extract showed only antibacterial activity. 
15. Vinoth B et al., 54 (2015) reported the different extracts of A. tetracantha root 
for antioxidant potential using different invitro assays such as inhibition of 
DPPH, ABTS, hydroxyl radical and superxide anions. The total phenolic 
contents and ferric reducing antioxidant power of the extracts were also 
determined by using standard phytochemical reaction methods.  
16. Muthuswamy P et al., 45 (2012) performed the antioxidant study of methanol 
and ethyl acetate leaf extract of Azima tetracantha Lam. They also determined 
the inhibition of the LPO, DPPH, superoxide anion, hydroxyl radical.  
17. Gayathri G et al., 51 (2011) studied the antioxidant effect of leaf extracts of 
Azima tetracantha Lam. The report concluded that the leaves of A. tetracantha 
were proved to be good source of natural phenolic compounds. 
18. Hepsibha BT et al., 55 (2010) evaluated antioxidant and free radical scavenging 
activities of Azima tetracantha Lam. leaf extracts. The result suggested that the 
methanolic extract of A. tetracantha leaves showed better free radical capacity 
against different reactive oxygen /nitrogen species. 
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19. Antonisamy P et al., 56 (2011) evaluated the anti-inflammatory, analgesic and 
anti-pyretic effects of friedelin. The effects of friedelin on inflammation were 
studied by using carrageenan-induced hind paw oedema, croton oil-induced ear 
oedema, acetic acid-induced vascular permeability, cotton pellet-induced 
granuloma and adjuvant-induced arthritis.  
20. Ismail TS et al., 57 (1997) investigated the anti-inflammatory activity of Salacia 
oblonga root bark powder and Azima tetracantha leaf powder in male albino 
rats using carrageenan-induced rat paw oedema (acute inflammation) and cotton 
pellet granuloma (chronic inflammation) methods. The study concluded that 
both the crude drugs were optimally active at a dose of 1000 mg/kg.  
21. Konda VR et al., 58 (2015) evaluated the nephroprotective effect of root extract 
of Azima tetracantha in glycerol-induced acute renal failure in wistar albino 
rats. The study report suggested that there was a considerable improvement in 
biochemical parameters and histopathological changes when compared with 
glycerol treated group.  
22. Manikandaselvi S et al., 59 (2012) studied the significant elevation in the levels 
of urea, GGT and creatinine in ferrous sulphate induced group compared to 
control. After treatment with Azima tetracantha Lam., there was a significant 
decrease in the levels near to normal compared to ferrous sulphate induced 
group.  
23. Soumya A and Nagarajan V 60 (2014) performed that the aqueous extracts of 
Azima tetracantha showed a significant reduction in all the biochemical 
parameters of liver damage glucose, protein, bilirubin, cholesterol, ALP, SOD, 
CAT, Vitamin E, TBARS, Albumin and globulin elevated by ferrous sulphate. 
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24. Sunil C et al., 61 (2013) reported the antioxidant, free radical scavenging and 
liver protective effects of friedelin isolated from the leaves of Azima tetracantha 
Lam. They also concluded that, friedelin restored the levels of SGOT, SGPT, 
LDH, SOD, catalase (CAT), reduced glutathione (GSH) and glutathione 
peroxidase (GPx) and showed liver protection, compared to standard drug 
silymarin. 
25. Sambasivam  M et al., 62 (2013) reported that the hepatoprotective potential of 
Azima tetracantha and Tribulus terrestris on ferrous sulfate-induced toxicity in 
rat revealed that the hydroalcoholic extract of leaf powder of Azima tetracantha 
and the fruit powder of Tribulus terrestris retrieved the liver parameters to usual 
level and possesses significant hepatoprotective activity. 
26. Balakrishnan M et al., 63 (2012) reported that the ethanolic extract (50%) of 
Azima tetracantha Lam. (EEAT) root bark afforded significant protection 
against carbon tetrachloride (CCl4) induced hepatocellular injury.  
27. Nargis BT et al., 64 (2011) revealed that, the rats treated with ethanolic extract 
of A. tetracantha showed a significant reduction in all the five-biochemical 
parameters of liver damage (AST, ALT, ALP, ACP and total bilirubin) elevated 
by carbon tetrachloride.  
28. Arthika S et al., 65 (2011) reported that the EEAT reduced the hepatotoxin 
intoxication induced elevated biochemical parameters and decrease the protein 
synthesis and accumulation of triglycerides leading to fatty liver. 
29. Maruthi TE et al., 66 (2010) provided the scientific evidence on the correlative 
effects of hepatoprotective activities of Azima tetracantha Lam. It indicates that 
the chloroform and ethanol extracts of A. tetracantha reduced the hepatotoxin 
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intoxication induced elevated biochemical parameters and decreased the protein 
synthesis.  
30. Antonisamy P et al., 67 (2015) reported the protective effects of friedelin 
isolated from Azima tetracantha Lam., against ethanol-induced gastric ulcer in 
rats. The result from the study showed that the friedelin isolated from the 
hexane extract of leaves of Azima tetracantha protected from ethanol caused 
severe gastric damage. 
31. Muthusamy P et al., 68 (2009) performed that, EEAT showed notable dose-
dependent ulcer protective effect against cold restraint stress and aspirin plus 
pylorus ligation induced gastric ulcers.  
32. Nargis BT et al., 69 (2009) studied the anticancer activity of Azima tetracantha 
leaf extract on Ehrlich Ascites Carcinoma (EAC) in mice. Ethanol extract of 
Azima tetracantha (EEAT) was evaluated the parameter such as mean survival 
time, tumor volume, viable tumor cells count and non-viable tumor cells count. 
They concluded that, the oral administration of EEAT increased the survival 
time, and also reduce the solid tumor volume, viable tumor cells count and 
increased the non-viable tumor cells count. 
33. Begum HV et al., 70 (2013) reported that, the aqueous crude extract of the 
leaves of Azima tetracantha for its antidiarrhoeal activity using castor oil-
induced diarrhoea and castor oil-induced enteropooling in rats. 
34. Nargis BT et al., 71 (2009) investigated that, the ethanolic leaf extract of Azima 
tetracantha Lam., for its hypoglycemic and hypolipidemic activity in alloxan-
induced diabetic albino rats. They also concluded that, the reduction in the 
plasma glucose and in the lipid profile was slightly less than that achieved with 
the standard drug glibenclamide. 
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CHAPTER 3 
RATIONALE FOR SELECTION 
 Cancer is a multi-step disease incorporating physical, environmental, 
metabolic, chemical and genetic factors, which play a direct and/ or indirect role in 
the induction and deterioration of cancers. 
 Diet with high consumption of anti-oxidant rich fruits and vegetables 
significantly reduces the risk of many cancer diseases suggesting that confident anti-
oxidants could be effective agents for the inhibition of cancer spread. 
 These agents present in the diet are a group of compounds with low toxicity, 
safe and generally accepted. 
 Recent researches revolve round the urgency to evolve suitable chemotherapy 
consistent with new discovery in cell biology for the treatment of cancer with no toxic 
effects. 
 Presently various therapies are available for the treatment of cancer such as 
chemotherapy, radiotherapy etc. besides these expensive therapies, phytotherapy play 
a significant role for the treatment of cancer. 
 Since medieval times, plants have been the source of medicines for the 
treatment of diseases. Regardless of the availability of a wealth of synthetic drugs, 
plants remain even in the 21st century an integral part of the health care in different 
countries, especially in the developing ones. 
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 In the late 90’s, the WHO stated that a big percentage of the world’s 
population depends on plant based therapies to cover the needs of the primary health 
care (WHO 1999). 
 Moreover, towards the end of the 20th century, plant based products, 
nutraceuticals and food supplements comprising the complementary and alternative 
therapies have gained a big share in the drug market of developing countries. 
 Considering the vast potentiality of plants as a source of traditional medication 
a systematic investigation was carried out to evaluate their anticancer properties. 
Therefore, efforts are still being made for the search of effective naturally 
occurring anti-carcinogen that would prevent, slow or reverse cancer development. 
Plants have a special place in the treatment of cancer. 
So, this was the inspiration to find an herb having anticancer activity which 
has been claimed scientifically on extract and the present research work is to isolate 
the bioactive compound which is responsible for anticancer activity. 
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CHAPTER 4 
AIM AND OBJECTIVE 
4.1. AIM 
 The project directly aims to isolate bioactive compounds from Azima 
tetracantha Lam., which will have a curative effect on cancer disease. 
4.2. OBJECTIVE 
 To standardize the leaves and stem of Azima tetracantha Lam., by carrying 
out the pharmacognostical and phytochemical studies. 
 To prepare various extracts (Ethanol and Hexane extracts of Azima 
tetracantha Lam. leaf and stem). 
 To evaluate the invitro anticancer activity of various extracts to identify the 
active extract using MTT assay. 
 To isolate the bioactive compounds from the active extract by Bioactivity 
guided isolation using Column chromatography. 
 To evaluate the invitro antioxidant activity (DPPH assay) of all the fractions 
and isolated bioactive compounds eluted from the column to identify the 
active compounds. 
 Structural characterization of isolated bioactive compounds by UV, IR, 
NMR and Mass spectroscopy. 
 To evaluate the invivo acute toxicity of all isolated bioactive compounds. 
 To evaluate in-vitro anticancer activity of isolated bioactive compound by 
MTT assay. 
   Docking studies of isolated bioactive compound with various targeting 
enzymes (PDB-ID 4O33, 2Y3I, 3UEN, 3ZOZ). 
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CHAPTER 5 
PLAN OF WORK 
5.1.  PHARMACOGNOSTICAL STUDIES 
 Collection and identification of the plant material 
 Organoleptic characters 
 Macroscopic Study 
 Microscopic study 
 Powder microscopy 
 Quantitative Microscopy 
 Determination of Stomatal Number and Stomatal Index 
 Determination of Vein islet Number and Veinlet termination   
      Number 
 Physicochemical Studies 
 Determination of Foreign organic matter 
 Determination of Loss on Drying 
 Ash value 
 Determination of Total ash 
 Determination of Acid insoluble ash 
 Determination of water soluble ash 
 Determination of Sulphated ash 
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 Extractive value 
 Determination of water soluble extractive value 
 Determination of Ethanol soluble extractive value 
 Determination of Ether soluble extractive value 
 Determination of volatile oil content 
 Determination of Swelling Index 
 Determination of Foaming Index 
 Inorganic metal analysis  
 Qualitative analysis of Inorganic elements 
5.2. PHYTOCHEMICAL STUDIES 
 Extraction of Plant material 
 Qualitative phytochemical screening 
 Fluorescence analysis 
 Thin layer chromatography  
 Selection of Active Extract 
 Invitro anticancer activity (MTT Assay) 
 Bioactivity Guided Isolation 
 Column Chromatography 
 Thin layer chromatography 
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 Selection of Active Fraction 
 Invitro antioxidant activity (DPPH assay) 
 Spectral studies 
 Ultraviolet Spectroscopy 
 Infrared Spectroscopy 
 Nuclear Magnetic Resonance Spectroscopy 
 Mass Spectroscopy 
5.3. PHARMACOLOGICAL STUDIES 
 Acute toxicity studies  
By Acute toxic class method (OECD Guidelines 402) 
 Invitro anticancer activity of bioactive compound 
5.4. DOCKING STUDIES 
Docking with various anticancer drug targeting enzymes 
 PDB-ID 4O33  
 PDB-ID 2Y3I 
 PDB-ID 3UEN 
 PDB-ID 3ZOZ 
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CHAPTER 6 
PLANT PROFILE 
Azima tetracantha Lam. 
6.1. TAXONOMICAL STUDIES 
Family72      : Salvadoraceae 
Synonyms72,73: Monetia barlerioides L’Herit.  
  Azima nova J. F. Gmel. 
     Kandena spinosa Rafin. 
    Monetia angustifolia Boj. Ex A. DC. 
    Monetia tetracantha (Lam.) Salisb. 
Scientific classification73,74
 
Phylum    : Tracheophyta 
Class        : Magnoliopsida  
Order       : Capparales  
Family     : Salvadoraceae 
Genus      : Azima 
Species    : Azima tetracantha lam. 
Vernacular names73, 75 
Sanskrit       : Kundali 
Hindi           : Kanta- gur-kamai 
Malayalam   : Essanku, Sankukuppi, yeshenku 
English        : Bee sting bush, Fire thorn, Needle bush, Mistletoe 
Tamil           : Sung-ilai 
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6.2. DESCRIPTION76 
Azima tetracantha Lam., belongs to Salvodoraceae and known as Kundali in 
Ayurvedic medicine. Azima tetracantha is a perennial shrub growing upto 3m in hot, 
dry riverine scrub, particularly on alluvial or saline soil. The plant is dioecious, erect 
shrub with (1–)2 spines 0.5–5 cm long in each leaf axil, sometimes scandent with stems 
up to 8 m long; branchlets are terete or quadrangular, glabrous to densely hairy. The 
leaves of the plant are elliptical in shape and are rigid, pale green colored. The flowers 
are small, greenish white (or) yellow colored, unisexual in axillary fasciles. Fruits are 
globular, white shiny. Seeds are compressed, circular. It occurs naturally in central, 
eastern and southern Africa as well as in the Indian Ocean Islands, and extends through 
Arabia to tropical Asia. 
 
 
Fig 5: Plant- Azima tetracantha Lam. 
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Chemical Constituents47 
Table 3: The chemical constituents present in Azima tetracantha. 
Class Chemical Constituents 
Glucosinolates and glucosinolate derived 
compounds 
3- indolylmethylglucosinolate 
N- hydroxyl- 3- indolylmethyl- 
glucosinolate 
N- methoxy- 3- indolylmethyl- 
glucosinolate 
Neoascorbigen  
Dimeric piperidine alkaloids 
Azimine 
Azcarpaine 
Carpaine 
 
Medicinal importance of A. tetracantha72 
    Azima tetracantha is a potent diuretic76 to treat rheumatism, dropsy, dyspepsia, 
chronic diarrhorea; it is used as stimulant tonic after child birth. A. tetracantha is used 
to treat cough, phthisis, asthma, small pox and diarrhorea. Rheumatism has been cured 
by its leaves, root and root bark.77  
 
Traditional Uses 
Traditionally, root used as diuretic. In Siddha, root is used in the treatment for 
dropsy and rheumatism. It is also used as analgesic78 and anti-inflammatory.57 
Leaves are used as stimulant, expectorant and antispasmodic. It is also used in 
cough and asthma. Bark is used as antiperiodic, astringent and expectorant.  
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In western India, juice of the leaves is applied as ear drops against earache and 
crushed leaves are placed on painful teeth.  
In India and Sri Lanka the root, root bark and leaves were administered with 
food as a remedy for rheumatism, dropsy, dyspepsia, chronic diarrhea and is considered 
as stimulant tonic and given to pubertal women immediately after confinement.79,80 
 Locally, the traditional healers from Tirunelveli district of Tamilnadu use the 
root bark (paste with buttermilk) as potent remedy for jaundice.80
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CHAPTER 7 
PHARMACOGNOSTICAL STUDIES 
The study of plant drugs from the pharmacognostical stand point would 
include the study of the habitat, general characters of the plant from which the drug is 
derived, its place in the botanical system, the organ or the organs of the plant used, 
their gross, minute structures in the whole and in the powdered conditions and the 
chemistry of the constituents especially of those which may be used in therapeutics. 
The macroscopic and microscopic description of a medicinal plant is the first 
step towards establishing the identity and the degree of purity of such materials. This 
should be carried out before any tests are undertaken. Lack of proper standards of 
medicinal plants may result in the usage of improper drugs which in turn will cause 
damage not only to the individual using it, but also to respect gained by the well-
known ancient system of medicine and the entire work on the plant becomes invalid. 
Thus, in recent years there has been an emphasis in pharmacognostical 
standardization of medicinal plants of therapeutic potential. So, the present study is 
undertaken to standardize Azima tetracantha Lam., pharmacognostically which will 
help in the correct identification of the drug. 
 
7.1. MATERIALS AND METHODS 
Collection and identification of Plant materials 
The plant materials (leaves and stem) of Azima tetracantha Lam., were 
collected from Vellore district, Tamilnadu, India. The collected plant materials were 
botanically identified and authenticated by the Dr. G.V.S Murthy, Scientist ‘F’, 
Botanical Survey of India, under reference number BSI/SRC/5/23/2016/Tech./178. 
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The herbarium specimen was prepared and deposited at Department of 
Pharmacognosy, College of Pharmacy, Madras Medical College, for future reference. 
The shade dried leaves and stem were coarsely powdered and used for further studies. 
Organoleptic characters81 
Organoleptic evaluation can be done by means of sense organs, which provide 
the simplest as well as quickest means to establish the identity and purity to ensure 
quality of particular drug. Organoleptic characters such as shape, size, colour, odour, 
taste and fracture of stem bark, leaf structure like margin, apex, base surface, 
venation, and inflorescence etc were evaluated.  
MACROSCOPIC STUDY82-84 
The macroscopic study is the morphological description of the plant parts 
which are seen by naked eye or magnifying lens.  
MICROSCOPIC STUDY85-92 
The microscopic study is the anatomical study which is done by taking 
appropriate section of the plant parts. 
Staining method 
 Fixation of Plant organ- Different organ samples were cut and fixed in FAA 
solution (Formalin- 5ml, Acetic acid- 5ml, 70% Ethanol- 90ml) 
 Dehydration of specimen- After 24 hours of fixing, the plant parts like leaves, 
stem and thorns were graded with series of tert- butyl alcohol, as per the standard 
method. 
 Infiltration of specimen- It was carried out by gradual addition of 58-60°C 
melting pointed paraffin wax until TBA solution attained super saturation. The 
specimens were cast into paraffin blocks. 
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Sectioning 
The paraffin embedded specimens were sectioned with the help of Rotary 
Microtome. The thickness of the sections was 10-12µm. Dewaxing of the sections 
was done by customary procedures. Since toluidine blue is a polychromatic stain, the 
sections were stained as per the method published by O’Brein et al., (1964) the 
staining results were remarkably good. 
The dye rendered pink colour to the cellulose walls, blue to the lignifies cells, 
dark green to suberin, violet to mucilage, blue to protein bodies etc.  
Photomicrographs 
Microscopic description of tissues was supplemented with micrographs 
wherever necessary.  
 Photographs of different magnifications were taken with Nikon lab photo 2 
microscopic units. For normal observations bright field was used.  
 For the study of crystals and lignified cells, polarized light was used. Since, 
these structures have bifringent property under polarized light they appear 
bright against dark background. Magnifications of the figures are indicated by 
the scale-bars. Descriptive terms of the anatomical features are as given in the 
standard anatomy books. 
Powder microscopy83-86 
 The shade dried, powdered plant material was used for powder microscopic 
analysis. The organoleptic characters were observed and to identify the different 
characteristic features using various staining reagents. 
 Powder was stained with 1% phloroglucinol in 90% ethanol, conc. 
hydrochloric acid and glycerin further observed under microscope. All the lignified 
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cells stained pink colour. Calcium oxalate crystals were observed under polarized 
light microscope. 
Quantitative Microscopy83 
 Quantitative microscopic parameters such as stomatal number, stomatal index, 
vein islet number and veinlet termination number were studied in the present study. 
Determination of Stomatal Number and Stomatal Index 
 Stoma (plural- stomata) is a minute epidermal opening covered by two kidney 
shaped guard cells in dicot leaves. These guard cells, in turn, are surrounded by 
epidermal (subsidiary) cells. Stomata perform the functions of gaseous exchange and 
transpiration in plants. The nature of the stomata, as well as, the stomatal index and 
stomatal number are important diagnostic characteristics of dicot leaves. 
 Stomatal number is defined as the average number of stomata per sq mm of 
epidermis of the leaf. The actual number of stomata per sq mm may vary for the 
leaves of the same plant grown in different environment or under different climatic 
conditions. It is, however, shown that the ratio of the number of stomata to the total 
number of epidermal cells in a given area of epidermis is fairly constant for any age of 
the plant and under different climatic conditions. 
Stomatal index is the percentage which the number of stomata form by the 
total number of epidermal cells, each stoma being counted as one cell. Stomatal index 
can be calculated by using the following equation. 
S 
S.I=                  X 100 
E+S 
Where S.I = Stomatal Index 
 S = Number of stomata per unit area 
 E = Number of epidermal cells in the same unit area 
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Procedure 
 Clear the fragments of the leaf from the middle lamina by boiling with 70% 
alcohol and 5% sodium hydroxide, subsequently washed with water. Peel out 
upper and lower epidermis separately. 
 Prepare the mounts of low and upper epidermis separately in glycerin water. 
 Draw a square of known dimensions by means of a stage micrometer and 
camera lucida on a drawing paper. 
 Replace the stage micrometer by the cleared leaf preparation, focus under the 
same magnification and trace the epidermal cells and stomata by looking 
through the microscope when a superimposed image of the leaf is seen at the 
same time.  
 The number of epidermal cells and stomata within the square was counted. 
Determination of Vein islet Number and Veinlet termination Number 
 The mesophyll of the leaf in dicot leaves is divided into small portions by 
branching of the veins throughout the tissues. The small areas of the green tissue 
outlined by the veinlets are termed as vein-islets. Vein-islet number is defined as the 
number of vein-islets per sq mm of the leaf surface midway between midrib and the 
margin. It is a constant for a given species of the plant and used as a characteristic for 
the identification of the allied species. Veinlet termination number is defined as the 
number of veinlet termination per sq mm of the leaf surface midway between midrib 
and the margin. A vein termination is the ultimate free termination of veinlet. 
Procedure 
 Boil a few leaves in chloral hydrate solution and placed in a boiling water-
bath.  
 Mount the preparation in glycerin water. 
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 Set up the camera lucida and divide the paper into squares of 1 sq mm by 
means of stage micrometer. 
 Replace the stage micrometer by the cleared leaf preparation and trace the 
veins in four continuous squares.  
 Trace the vein-islets and veinlet termination by looking through the 
microscope when a superimposed image of the leaf and paper is seen at the 
same time.  
 The number of epidermal cells and stomata within the square was counted. 
PHYSICOCHEMICAL STUDIES93-99 
 The powdered plant materials were morphologically and organoleptically 
screened and subjected to physicochemical analysis in accordance with standard 
guidelines. 
Determination of Foreign organic matter 
 Medicinal plant materials should be entirely free from visible sign of 
contamination by moulds or insects, and other animal contamination, including 
animal excreta. No abnormal odour, discoloration, slime or signs of deterioriation 
should be detected. It is seldom possible to obtain marketed plant materials that are 
entirely free from harmful foreign matter or residue. 
 Macroscopic examination can conveniently be employed for determining the 
presence of foreign matter in whole or cut plant materials. However, microscopy is 
indispensable. 
Procedure 
 100g of the plant sample to be examined was weighed and spread out in a thin 
layer. The foreign matter was detected by inspection with the unaided eye, separated, 
weighed and calculated the percentages of foreign matters present.  
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Determination of Loss on Drying 
 Loss on drying is the loss in weight in %w/w resulting from water and volatile 
matter of any kind that can be driven off under specified conditions. If the sample is 
in the form of large crystals, reduce the size by rapidly crushing to a powder. 
Procedure 
 About 5g of the powdered drug was weighed accurately in a tarred petridish 
which was previously dried at 105°C in hot air oven and weighed. The drug was 
distributed as evenly as practicable in the petridish and dried at 105°C to constant 
weight. Calculate the percentage loss in weight with reference to the air-dried 
powdered drug.  
Ash value 
 Ash values are used to determine the quality and purity of a crude drug. It 
indicates the presence of various impurities like carbonate, oxalate and silicate. The 
residue remaining after incineration is called ash content of the drug, which simply 
represents inorganic salts, naturally occurring in drug or adhering to it or deliberately 
added to it, in the form of adulteration. Hence, an ash value determination furnished 
the basis for judging the identity and cleanliness of any drug and gives information 
relative to its adulteration or contamination with inorganic matter. 
Determination of Total ash 
 Place about 2g of the ground air-dried material, accurately weighed in a 
previously ignited and tared crucible. Spread the material in an even layer and ignite it 
by gradually increasing the heat to 500-600°C until it is white, indicating the absence 
of carbon. Cool in a desiccator and weigh. Calculate the content of total ash in mg per 
g of air-dried material. 
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Determination of Acid insoluble ash 
 The acid insoluble ash consist mainly silica and indicate contamination with 
earthy material. To the crucible containing the total ash, add 25 ml of 2M 
hydrochloric acid for 15 minutes. The insoluble matter was collected in an ashless 
filter paper, washed with hot water, ignited and cooled in a dessicator and weighed. 
Calculate the content of acid insoluble ash in mg per g of air-dried material. 
Determination of water soluble ash 
 The water soluble ash is used to estimate the amount of inorganic compound 
present in drugs. To the crucible containing the total ash, add 25 ml of water and boil 
for 5 minutes. Collect the insoluble matter in an ashless filter paper, washed with hot 
water and ignited for 15 minutes at a temperature not exceeding 450°C. Subtract the 
weight of this residue in mg from the weight of total ash. Calculate the content of 
water soluble ash in mg per g of air-dried material. 
Determination of Sulphated ash 
 About 3g of accurately weighed air dried powdered drug was taken in a silica 
crucible, which was previously ignited and weighed. Then ignite gently until the drug 
was thoroughly charred. The crucible was cooled and the residue was moistened with 
1 ml of concentrated sulphuric acid, heat gently until the white fumes were no longer 
evolved and ignited at 800±25°C until all the black particles has disappeared. The 
crucible was allowed to cool, add few drops of sulphuric acid and heated. The ignition 
was carried out as before, allowed to cool and weighed to a constant weight 
(difference is not exceeding 0.5g between two consecutive reading). Calculate the 
percentage of sulphated ash with reference to the air-dried drug. 
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Extractive value 
 Extractive values of crude drugs are useful for their evaluation, especially 
when the constituents of a drug cannot be readily estimated by any other means. 
Further, these values indicate the nature of chemical constituents present in a crude 
drug.  
Determination of water soluble extractive value 
 5g of macerated and air dried coarse powder of sample was mixed with 100 ml 
of chloroform water and kept in a closed flask for 24 hours, shaking frequently during 
the first 6 hours and then allowed to stand for 18 hours. Thereafter, it was filtered 
rapidly, taking precautions against loss of solvent. 25 ml of the filtrate was evaporated 
to dryness in a tared flat-bottomed shallow dish, dried at 105C and weighed. Calculate 
the percentage of water-soluble extractive with reference to the air-dried drug. 
Determination of Ethanol soluble extractive value 
 5g of macerated and air dried coarse powder of drug was mixed with 100 ml 
of 95% ethanol in a closed flask for 24 hours, shaking frequently during the first 6 
hours and then allowed to stand for 18 hours. Thereafter, it was filtered rapidly, taking 
precautions against loss of solvent. 25 ml of the filtrate was evaporated to dryness in a 
tared flat-bottomed shallow dish, dried at 105C and weighed. Calculate the percentage 
of ethanol soluble extractive with reference to the air-dried drug. 
Determination of Ether soluble extractive value 
5g of macerated and air dried coarse powder of sample was mixed with 100 ml of 
ether and kept in a closed flask for 24 hours, shaking frequently during the first 6 
hours and then allowed to stand for 18 hours. Thereafter, it was filtered rapidly, taking 
precautions against loss of solvent. 25 ml of the filtrate was evaporated to dryness in a 
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tared flat-bottomed shallow dish, dried at 105C and weighed. Calculate the percentage 
of ether soluble extractive with reference to the air-dried drug. 
Determination of volatile oil content 
 Volatile oils are characterized by their odour, oil-like appearance and ability to 
volatilize at room temperature. Chemically, they are usually composed of mixtures of, 
for example, monoterpenes, sesquiterpenes and their oxygenated derivatives. 
Aromatic compounds predominate in certain volatile oils. 
Determination of Swelling Index 
 Many herbal materials are of specific therapeutic or pharmaceutical utility 
because of their swelling properties-especially gums and those containing an 
appreciable amount of mucilage, pectin or hemicellulose. 
The swelling index is the volume in ml taken up by the swelling of 1 g of 
herbal material under specified conditions. Its determination is based on the addition 
of water or a swelling agent as specified in the test procedure for each individual 
herbal material (either whole, cut or pulverized). Using a glass-stoppered measuring 
cylinder, the material is shaken repeatedly for 1 hour and then allowed to stand for a 
required period of time. The volume of the mixture (in ml) is then read. 
The mixing of whole herbal material with the swelling agent is easy to 
achieve, but cut or pulverized material requires vigorous shaking at specified intervals 
to ensure even distribution of the material in the swelling agent. 
Procedure 
Carry out simultaneously no fewer than three determinations for any given 
material. Introduce the specified quantity of the herbal material concerned, previously 
reduced to the required fineness and accurately weighed, into a 25-ml glass-stoppered 
measuring cylinder. The internal diameter of the cylinder should be about 16 mm, the 
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length of the graduated portion about 125 mm, marked in 0.2- ml divisions from 0 to 
25 ml in an upwards direction. Unless otherwise indicated in the test procedure, add 
25 ml of water and shake the mixture thoroughly every 10 minutes for 1 hour. Allow 
to stand for 3 hours at room temperature, or as specified. Measure the volume in ml 
occupied by the herbal material, including any sticky mucilage. Calculate the mean 
value of the individual determinations, related to 1 g of herbal material. 
Determination of Foaming Index 
Many herbal materials contain saponins that can cause persistent foam when 
an aqueous decoction is shaken. The foaming ability of an aqueous decoction of 
herbal materials and their extracts is measured in terms of a foaming index. 
Procedure 
Reduce about 1 g of the herbal material to a coarse powder (sieve size no. 
1250), weigh accurately and transfer to a 500-ml conical flask containing 100 ml of 
boiling water. Maintain at moderate boiling for 30 minutes. Cool and filter into a 100-
ml volumetric flask and add sufficient water through the filter to dilute to volume. 
Pour the decoction into 10 stoppered test-tubes (height 16 cm, diameter 16 mm) in 
successive portions of 1 ml, 2 ml, 3 ml, etc. up to 10 ml, and adjust the volume of the 
liquid in each tube with water to 10 ml. Stopper the tubes and shake them in a 
lengthwise motion for 15 seconds, two shakes per second. Allow to stand for 15 
minutes and measure the height of the foam. The results are assessed as follows: 
 If the height of the foam in every tube is less than 1 cm, the foaming index is 
less than 100. 
 If a height of foam of 1 cm is measured in any tube, the volume of the herbal 
material decoction in this tube (a) is used to determine the index. If this tube is the 
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first or second tube in a series, prepare an intermediate dilution in a similar manner to 
obtain a more precise result. 
  If the height of the foam is more than 1 cm in every tube, the foaming index is 
over 1000. In this case repeat the determination using a new series of dilutions of the 
decoction in order to obtain a result. Calculate the foaming index using the following 
formula: 
1000 
a 
Where a = the volume in ml of the decoction used for preparing the dilution in the 
tube where foaming to a height of 1 cm is observed. 
INORGANIC METAL ANALYSIS 
 Plant minerals play a vital role in metabolism and osmolality. Presence of 
elements vary with the soil, climatic conditions etc. There are essential and non 
essential elements which may be beneficial or harmful to living things. Non-essential 
elements like lead, arsenic, cyanide, chromium, cadmium, aluminium, silver bring 
about toxic effects resulting in intoxication. Hence, qualitative and quantitative 
estimation of inorganic elements in the leaves and stem of Azima tetracantha Lam., 
were carried out 
Qualitative analysis of Inorganic elements81 
 To the ash of powder material, 50% v/v HCl was added and kept for 1 hour. It 
was filtered and the filtrate was used for the following tests. 
Aluminium 
 White gelatinous precipitate of aluminium hydroxide is formed on addition of 
ammonia solution. It is slightly soluble in excess of the reagent. The precipitate 
dissolves readily in strong acid and base. But after boiling it becomes insoluble. 
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Arsenic  
 Arsenous salts in neutral solution react with solution of copper sulphate to 
form green precipitate (Scheele’s green) which on boiling ggives a red precipitate of 
cupric oxide. 
Borate 
 The mixture obtained by the addition of sulphuric acid and alcohol (95%) to a 
borate when ignited, burns with flame tinged with green. 
 
Calcium 
 Solution of calcium salts, when treated with ammonium carbonate solution, 
yield a white precipitate after boiling and cooling the mixture (it is insoluble in 
ammonium chloride solution). 
Carbonates 
Carbonate, when treated with dilute acid, effervescence liberating carbon 
dioxide which is colourless and produces a white precipitate in calcium hydroxide 
solution. 
Chlorides 
 Chlorides, when treated with silver nitrate solution, yield a white crude 
precipitate which is insoluble in nitric acid, but soluble after being well washed with 
water, in diluted ammonia, from which it is re-precipitaed by the addition of nitric 
acid. 
Copper 
An excess of ammonia, added to a solution of a cupric salt, produces first a 
bluish precipitate and then a deep blue coloured solution. 
 
49 
 
Iron 
Solution of ferric salts, when treated with potassium ferrocyanide solution, 
yields an intense blue precipitate which is insoluble in dilute HCl. 
Lead 
 Strong solution of lead salts, when treated with HCl, yield a white precipitate 
which is soluble in boiling water and is deposited as crystals when the solution is 
cooled. 
Magnesium 
Solution of magnesium salts, when treated with ammonium carbonate solution 
and boiled, yield a white precipitate, but yield no precipitate in the presence of 
ammonium chloride solution. 
Mercury 
 Solution of mercury salts, when treated with sodium hydroxide solution, yields 
a yellow precipitate. 
Nitrate 
With solution of ferrous sulphate no brown colour was observed but if 
sulphuric acid is added (slow from the side of the test tube), a brown colour is 
produced at the junction of two liquids, indicating the presence of nitrates. 
Phosphates 
Solution of phosphate when treated with silver nitrate, dilute ammonia 
solution and in dilute nitric acid yellow precipitate of normal silver ortho phosphate 
(distinction from meta and pyrophosphate) solution. 
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Potassium 
 Moderately strong potassium salts, which have been previously ignited to 
remove ammonium salts, when treated with perchloric acid (60%) yield a white 
crystalline precipitate. 
Silver 
Solution of silver salts, when treated with potassium iodide solution yield a 
cream coloured precipitate which is insoluble in dilute ammonia solution and in nitric 
acid. 
Sulphates 
Solution of sulphates, when treated with lead acetate solution yields white 
precipitate which is insoluble in ammonium acetate solution and in sodium hydroxide. 
Quantitative estimation of Inorganic elements100,101 
Inductive coupled plasma-Optical emission spectroscopy (ICP-OES) 
It is an excellent multi-element technique with relatively good sensitivity and 
selectivity when configured correctly. This technique utilizes the plasma as an ion 
source or light emission source are capable of producing values. 
Quantitative analysis of Heavy metals 
Instrumentation parameters:  
Instrument name: Inductive coupled plasma-Optical emission spectroscopy  
Instrument Model: PE Optima 5300DV ICP-OES; Optical system Dual view-axial 
or radial Detector system: Charge coupled detector, (UV-Visible detector which is 
maintaining at -40ºC) to detect the intensity of the emission line. 
Light source (Torch): Positioned horizontally in the sample compartment along the 
central axis of the spectrometer optics. Changing from axial to radial viewing is a 
simple software command and is accomplished by computer control of a mirror 
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located in the optical path. The torch assembly of this system comprises of two 
concentric quartz tubes. 
Standard alumina injector: 2.0mm inner diameter.  
Spray chamber: Scott type  
Nebulizer: Cross flow gem tip. 
Preparation of sample by acid digestion method 
50mg of powder was treated with acid mixture of sulphuric acid: water in the 
ratio of 4:1in the Kjeldahl flask and heated continuously till the solution is colourless. 
The sample mixture was then transferred in a 25ml volumetric flask and made up to 
the volume with distilled water. Blank solution was prepared as above without 
sample. 
The standards of Arsenic, Lead, Mercury and Cadmium were prepared as per the 
protocol and the calibration curve was developed for each of them. 
Detection 
Samples were analyzed for the detection and quantification of the aluminium,  
calcium, chloride ,borate, silver, copper, potassium, magnesium, iron by Inductively 
Coupled Plasma Emission Spectrometry. 
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7.2. RESULTS  
Organoleptic characters 
Colour -   Dark green to pale green 
Odour -   Characteristic odour 
Taste -   Tasteless 
MACROSCOPIC STUDY 
Azima tetracantha is a perennial shrub growing upto 3m in hot, dry riverine 
scrub, particularly on alluvial or saline soil. The plant is dioecious, erect shrub with 
(1–)2 spines 0.5–5 cm long in each leaf axil, sometimes scandent with stems up to 8 
m long; branchlets are terete or quadrangular, glabrous to densely hairy. The leaves of 
the plant are elliptical in shape and are rigid, pale green colored. The flowers are 
small, greenish white (or) yellow colored, unisexual in axillary fasciles. Fruits are 
globular, white shiny. Seeds are compressed, circular.  
 
A) Leaf 
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B) Stem with thorns 
 
 
C) Flower 
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D) Fruits 
       
 
E) Length of leaf                                               D) Breadth of Leaf 
 
Fig 6: Macroscopy of Azima tetracantha Lam. 
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Table 4: Macroscopic evaluation of Azima tetracantha Lam. 
 
S. No Particulars Observations 
1. Apex Mucronate, sharp-tipped 
2. Base Acute base 
3. Margin Simple and entire 
4. Shape Aristate with a spine on tip 
5. Vein Cross venulate 
6. Stipules Absent or rudimentary 
7. Leaflets Pinnate 
   
\ 
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MICROSCOPICAL STUDY 
Leaf 
 The transverse section of leaf shown dorsiventral nature. Some of the 
important features were follows, 
Midrib: The midrib is flat on the adaxial side and hemispherical on the abaxial 
side. 
Vascular bundle: Single, top shaped and consists of a few parallel, short, 
radial multiples of vessels and an abaxial arc shaped phloem. 
Lamina: 230 μm thick. Both adaxial and abaxial sides are smooth and even. 
Epidermal tissues: The epidermal tissue as seen in paradermal section. 
Stomata: Anisocytic with four unequal subsidiary cells.  
Stem 
 Epidermis: Thin and the epidermal cells are squarish or rectangular, coated 
with thick cuticle.  
Vascular bundles: Radially elongated; a thick, semicircular mass of 
sclerenchymatous bundle. 
Pith: Wide, homogenous and parenchymatous, thick walled, vary in size. 
Thorns 
Epidermis: Vascular bundle is surrounded by a compact layer of thin walled 
parenchymatus cells. 
Pigments: Abundantly present 
Airsac: Air space present at the centre. 
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Fig 7: Transverse section of Azima tetracantha Leaf 
 
Fig 8: Transverse section of Azima tetracantha Stem 
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Fig 9: Transverse section of Azima tetracantha Thorn 
 
 
UE- Upper epidermis, La- Lamina, Pa- Palisade cells, Xy- Xylem, Ph- Phloem, MR- 
Midrib, LE- Lower epidermis, Sch- Sclerenchyma, LV- Lateral vein, AS- Airsac, VB- 
Vascular bundle, Pig- Pigments, HF- Hypodermal fibres, PF- Pericyclic fibres, Cu- 
Cuticle, Co- Cortex 
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Powder microscopy 
 The leaf powder showed the presence of parenchyma, sclerenchyma, 
trichomes, fibres, anisocytic stomata, crystal sheath of calcium oxalate and xylem 
vessels. The stem powder showed the presence of epidermis, fibres, pigments and 
xylem vessels. The powder characteristics of leaf and stem were shown in the Figure 
10 and Figure 11 Respectively 
 
         
A) Parenchyma     B) Sclerenchyma 
 
 
       
C) Trichomes      D) Fibres 
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       E) Stomata    F) Crystal sheath 
 
 
 
 
 
G) Xylem vessels 
Fig 10: Powder microscopy of Azima tetracantha Leaf powder 
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A) Epidermis     B) Fibres 
 
 
 
     
C) Pigments     D) Xylem vessels 
 
Fig 11: Powder microscopy of Azima tetracantha Stem powder 
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Quantitative microscopy 
Table 5: Quantitative microscopy of Azima tetracantha Leaf 
 
S. No Parameters Values 
1. Stomatal number- Lower epidermis 23-27 
2. Stomatal index- Lowder epidermis 19-20 
3. Vein islet number- Lowder epidermis 9-15 
4. Veinlet termination number- Lowder epidermis 15-19 
 
 
      
 
A                                                        B 
 
Fig 12: Quantitative microscopy of Azima tetracantha Leaf 
A) Stomata and B) vein-islets 
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PHYSICOCHEMICAL STUDIES 
Table 6: Physicochemical analysis of the leaves and stem of Azima tetracantha 
 
S. No Parameters Leaves Stem 
1.  Total ash 
7.45% 21.039% 
2.  Acid insoluble ash 
1.06% 0.493% 
3.  Water soluble ash  6.98% 13.985% 
4.  Sulphated ash 
15.35% 18.84% 
5.  Loss on drying  15.27% 11.95% 
6.  Water soluble extractive value 
1.593% 1.394% 
7.  Ethanol soluble extractive value 1.197% 0.399% 
8.  Foreign organic matter 
3.6% No 
9.  Volatile oil content 1.5%v/w No 
10.  Swelling Index 
No No 
11.  Foaming Index 
<100 <100 
 
n = 3 times 
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INORGANIC METAL ANALYSIS 
 
Table 7: Qualitative estimation of Inorganic elements in Azima tetracantha Lam., 
Leaf and stem 
 
S. No Inorganic elements Observation 
Leaves Stem 
1.  Aluminium + + 
2.  Arsenic + + 
3.  Borate - - 
4.  Calcium + + 
5.  Carbonate - - 
6.  Chlorides - - 
7.  Copper + + 
8.  Iron + + 
9.  Lead + + 
10.  Magnesium + + 
11.  Mercury - - 
12.  Phosphate - - 
13.  Potassium + + 
14.  Silver + - 
15.  Sulphate + + 
 
(+)- Present, (-)- Absent 
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Table 8: Quantitative estimation of inorganic elements of Azima tetracantha 
 
S.No 
 
Inorganic Elements 
 
Total Amount (%W/W) 
Leaves Stem  
1 
 
Aluminium 
 
0.028 
 
0.012 
2 
 
Chloride 
 
0.052 
 
0.037 
3 
 
Copper 
 
0.009 
 
0.011 
4 
 
Calcium 
 
0.010 
 
0.006 
5 
 
Sulphate 
 
0.028 
 
0.023 
6 
 
Borate 
 
0.005 
 
0.002 
7 
 
Potassium 
 
0.020 
 
0.0017 
8 
 
Silver 
 
0.008 
 
0.003 
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Quantitative estimation of Heavy metals by ICP OES method 
The quantification of the individual heavy metals was analyzed for the 
powdered mixture of Azima tetracantha Lam., by ICP-OES technique the following 
metals like arsenic, lead, cadmium were detected and quantified, results are given in 
the following Table 9. 
 
Table 9: Quantitative estimation of heavy metals in Azima tetracantha Lam.,  
Leaf and stem 
 
S. No Metals 
Results 
Specification 
Leaves Stem 
1. Mercury ND ND Not more than 0.5ppm 
2. Arsenic 0.084 0.013 Not more than 5.0ppm 
3. Lead 0.046 0.009 Not more than 10 ppm 
      4.  Cadmium 0.031 0.011 Not more than 0.3ppm 
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7.3. DISCUSSION 
Pharmacognostical standardization was carried out on the basis of detailed 
botanical evaluation of the leaves and stem which includes morphology and 
microscopy as well as WHO recommended physico-chemical studies. The results of 
the standardization may throw an immense light on the botanical identity of the leaves 
of Azima tetracantha Lam., which may furnish a basis of judging the authenticity of 
the plant and also to differentiate the drug from its adulterants and other species. 
The macroscopic characters were examined to identify the right crude drug. 
Microscopical Features 
Transverse section of the leaves showed a fairly prominent midrib, lateral 
veins and dorsiventral nature. The lamina has smooth even surface with two layers of 
palisade cells and anisocytic stomata with four unequal subsidiary cells. 
Transverse section of the stem showed epidermis with thick cuticle, vascular 
bundle and homogenous and parenchymatous, thick walled pith.  
 
Powder Characters 
The powder characters of a drug are mainly used in the identification of the 
drug in the powder form. The leaf powder is pale green in colour with characteristic 
odour. On micrsocopical examination the powder showed presence of parenchyma, 
sclerenchyma, trichomes, fibres, anisocytic stomata, crystal sheath of calcium oxalate 
and xylem vessels. The stem powder showed the presence of epidermis, fibres, 
pigments and xylem vessels. 
 
Quantitative Microscopy 
Quantitative microscopic data has been highly relied upon pioneer 
pharmacognosists and are found to be constant for a species. These values are 
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especially useful for identifying the different species of genus and also helpful in the 
determination of the authenticity of the plant. 
 
Physico-chemical Constants 
The physico-chemical parameters are mainly used in judging the purity and quality of 
the drug. An ash value of a drug gives an idea of the earthy matter or inorganic 
composition or other impurities present along with the drug. 
 
The ash values are important since ash may be derived from the plant itself 
(physiological or natural ash) as well as from the extraneous matter, especially sand 
and soil adhering to the surface of the drug (non physiological ash). The 
determination of physiological and non physiological ash together is called as total 
ash. The total ash may vary within wide limits for specimen of genuine drug due to 
variable natural or physiological ash, in such cases the ash obtained is treated with 
acid in which most of the natural ash is soluble leaving the silica as acid- insoluble 
ash which represents most of the ash from the contaminating soil. The ash values of 
the powdered leaves revealed a high percentage of sulphated ash. Any significant 
deviation in the percentage of ash reported in this work may indicate adulteration of 
the drug. 
 
Extractive values give an idea about the chemical constituents present in the 
drug as well as useful in the determination of exhausted or adulterated drugs. The 
result suggested that the powdered leaves have high water soluble extractive value. 
 
The loss on drying reveals the percentage of moisture present in the drug, 
since moisture facilitates the enzyme hydrolysis or growth of microbes which leads to 
deterioration. The swelling and foaming index was also studied.  
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Inorganic Mineral Analysis 
The presence of inorganic metals like aluminium, arsenic, calcium, carbonate, 
chloride, copper, iron, lead, magnesium, mercury, phosphate and sulphate in the leaf 
and stem powder were analyzed. It showed the presence of elements such as Al, Ar, 
Ca, Co, Fe, Pb, Mg, K, and SO4. The heavy metals are also present within the limits. 
 
This detailed pharmacognostical studies on the leaves of Azima tetracantha 
Lam., may substantiate as an essential data for the identification of raw material and 
also used to differentiate the plant from its allied species and adulterants. 
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CHAPTER 8 
PHYTOCHEMICAL STUDIES 
Phytochemistry is the study of phytochemicals, which are chemicals derived 
from plants.102 Techniques commonly used in the field of phytochemistry are 
extraction, isolation and structural elucidation of natural products as well as various 
chromatographic techniques. It is used for the discovery of new drugs. Phytochemical 
studies are used to find out the phytochemical constituents in the plants. 
 
Phytochemistry deals with the study of secondary metabolites synthesized in 
plants. It deals with the enormous variety of organic substances embedded in it. The 
phytochemistry also deals with chemical structure and its biological function. The 
beneficial therapeutic outcome of plant is based on its secondary metabolites. 
 
8.1. MATERIALS AND METHODS 
8.1.1. EXTRACTION OF PLANT MATERIAL 
Freshly harvested leaves and stem were air-dried at room temperature for a 
period for 2 weeks. Dried materials were coarsely grounded and stored in an air- tight 
container. About 200g of dried powdered leaves and stem were packed well in 
soxhlet apparatus and was subjected for hot extraction with hexane and ethanol 
(99.9%) at 18 hrs. The extract was filtered while hot and concentrated under Rotary 
vacuum evaporator in order to remove the solvent completely, dried and kept in a 
desiccator till further use. 
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Determination of Extract yield 
 The percentage yield of the leaves and stem of Azima tetracantha was 
determined by weighing the pulverized dried leaves and stem before extraction and 
the concentrated extracts obtained after extraction and then calculated using the 
formula. 
       Weight of extract obtained (g) 
Percentage Yield=                                                              X  100 
     Weight of crude powder taken (g) 
Qualitative phytochemical analysis103-108 
The extracts were tested for the presence of phytoconstituents using following 
standard methods. 
Test for Saponins 
To 0.5g of plant extracts, distilled water was added and heated for few 
minutes. Foam formation indicated the presence of saponins.  
Test for Tannins  
To 0.5g of plant extracts, 10ml of distilled water was added and filtered. To 
the filtrate 0.1% of ferric chloride solution was added. Formation of brownish green 
indicated the presence of tannins.  
Test for Steroids 
To 0.5g of plant extracts, 2ml of acetic anhydride and 2ml of sulphuric acid 
was added. Formation of violet-blue colour indicated the presence of steroids.  
Test for Flavonoids 
To 0.5g of plant extracts, a few drops of acetone was added and heated in a 
water bath until the acetone got evaporated and then filtered. The filtrate was cooled 
and 5ml sodium hydroxide was added. Presence of yellow colour indicated the 
presence of flavonoids.  
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Test for Alkaloids 
To 0.5g of plant extracts, 3ml of methanol was added with 10% acetic acid 
and ammonium hydroxide was added. Formation of precipitate indicated the presence 
of alkaloids.  
Test for Phenols 
To 0.5g of plant extracts, distilled water was added and heated, to that 2ml of 
ferric chloride was added. Blue / green colour formation indicated the presence of 
phenol.  
Test for Glycosides 
To 0.5g of plant extracts, 1ml of glacial acetic acid was added, and then ferric 
chloride and 1ml of sulphuric acid was added. Reddish brown colour appeared at the 
junction of two layers and the upper layer turned bluish green which indicated the 
presence of glycosides.  
Test for Carbohydrates 
300mg of 50% alcoholic extracts was dissolved in water and filtered. The 
filtrate was treated with concentrated sulphuric acid and then with Molisch’s regent. 
Appearance of pink or violet colour indicated the presence of carbohydrates. The 
filterate was boiled with Fehling’s and Benedict solution. Formation of brick red 
precipitate in Fehling’s and Benedict’s solution is the positive result for reducing 
sugars and non- reducing sugars respectively.  
Test for Triterpenoids 
5 ml of each extracts was mixed in 2ml of chloroform, and 3ml of 
concentrated sulphuric acid was carefully added to form a layer. A reddish brown 
colouration of the interface was formed to show positive result for the presence of 
terpenoid.  
73 
 
Test for Proteins 
Extracts were treated with 1 ml 10% sodium hydroxide solution separately and 
heated. A drop of 0.7% copper sulphate solution to the above mixtures was added. 
The formation of purple violet colour might be indicated the presence of protein. 
Fluorescence Analysis109-111 
The Fluorescence analysis of leaf and stem powder were carried out by mixing 
the powder with various chemical reagents and observing it under daylight, near UV 
and far UV. The extracts were also observed under UV light. 
Thin Layer Chromatography112 
 Thin layer chromatography is a technique used for the separation, 
identification and estimation of single or mixture of components present in the various 
extracts. It is a reliable technique in which solute undergoes distribution between two 
phases, stationary and mobile phase. The separation is mainly based on the 
differential migration that occurs when a solvent flows along the thin layer of 
stationary phase. This may be achieved by partition and adsorption depending on 
stationary phase used. 
TLC plates 
 Precoated readmade silica gel on an aluminium plates were used as a 
stationary phase. 
Sample application 
 The extracts to be analyzed were diluted with respective solvent and then 
spotted with the help of capillary tube just above 2cm above the bottom of the TLC 
plate. 
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Selection of mobile phase 
 Several mobile phases were tried for the separation of maximum components. 
Solvents were used in the order of increasing polarity. From the vast analysis, best 
solvents were selected as mobile phase which showed good separation with maximum 
number of components. 
Solvent system 
Hexane: ethyl acetate and ethyl acetate: ethanol: water of various ratios of 
mobile phase was used. The spots were visualized by exposing to iodine vapors and 
UV light. Rf values were noted down for each selected extracts after elution. 
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8.1.2. SELECTION OF ACTIVE EXTRACT 
 There has been an enormous interest in the development of alternative 
medicines for cancer, especially screening of phytochemicals with the ability to 
prevent or inhibit cancer growth. The goal of the present study was to provide invitro 
evidence for potential inhibition of cancer growth. Various extracts were examined at 
different concentrations of plant extracts using an invitro method to access possible 
effect on cancer cell line. The extracts with highest inhibitory effect on cancer cell 
line were selected for the isolation of bioactive compounds. 
In vitro anticancer activity (MTT Assay)113 
Extracts used: Hexane and Ethanol extracts of leaves and stem of Azima 
tetracantha Lam. 
Cell line used: MCF-7 Cell line 
Chemicals and reagents 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) 
invitrogen, USA. Acridine orange were obtained from Sigma, USA. All other fine 
chemicals were obtained from Sigma–Aldrich, St. Louis. 
Cell culture 
MCF-7 cells obtained from NCCS (National Centre For Cell Science, Pune) 
were cultured in Rose well Park Memorial Institute medium (RPMI), supplemented 
with 10% fetal bovine serum, penicillin/streptomycin (250 U/mL), gentamycin 
(100µg/mL) and amphotericin B (1mg/mL) were obtained from Sigma Chemicals, 
MO, USA. All cell cultures were maintained at 37◦C in a humidified atmosphere of 
5% CO2. Cells were allowed to grow to confluence over 24 h before use. 
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Cell growth inhibition studies by MTT assay 
Cell viability was measured with the conventional MTT reduction assay. 
Briefly, MCF 7 cells were seeded at a density of 5×103 cells/well in 96-well plates for 
24 hrs, in 200ul of RPMI with 10% FBS. Then culture supernatant was removed and 
RPMI containing various concentrations of test compound was added and incubated 
for 48 hrs. After treatment cells were incubated with MTT (10µl, 5mg/mL) at 37 ◦C 
for 4 h and then with DMSO at room temperature for 1 hr. The plates were read at 
595nm on a scanning multi-well spectrophotometer. Data represented the mean values 
for six independent experiments.  
Cell viability (%) = Mean OD/Control OD x 100 
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8.1.3. BIOACTIVITY GUIDED ISOLATION 
Bioactivity guided isolation method is commonly employed in drug discovery 
research due to its effectiveness to directly link the analyzed extract and targeted 
compounds using fractionation procedure that followed with certain biological activity. 
In pharmacognosy, a typical protocol to isolate a pure chemical agent from 
natural origin is bioactivity guided isolation, meaning step-by-step separation of 
extracted components based on differences in their physicochemical properties, and 
assessing the biological activity. 
Column Chromatography 
 Column chromatography is the oldest form of chromatographic technique. A tube is 
packed with a solid stationary phase, the sample mixture applied to the top of the 
column and the mobile phase is allowed to move down through the column under 
gravity. The constituents of the mixture move at different rates through the column as 
bands. Eventually they reach the end of the column and elute in solution in the mobile 
phase.114 
Isolation of compounds 
The crude ethanolic extract of Azima tetracantha (8g) was subjected to column 
chromatography (Silica gel 100- 200 mesh) with gradient elution using solvents of 
increasing polarity, hexane, hexane: chloroform, chloroform, chloroform: ethanol, 
ethanol; starting at 100:0; 95:5; 90:10; 85:15; 0:100%. Totally 45 fractions were 
eluted. The column flow rate was 1ml/min approximately 25 ml of 45 fractions was 
collected. TLC was carried out simultaneously for each fraction using hexane: ethyl 
acetate (7:3) and chloroform: ethanol (5:5). The spots were visualized either by 
exposing to iodine vapors and/or UV light. The fractions with similar Rf values were 
pooled together, concentrated to get pure compound.  
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8.1.4. SELECTION OF ACTIVE FRACTION 
 The reactive oxygen species of endogenous and exogenous source involved in 
etiologie of human diseases such as arteriosclerosis, neurogenerative disease, cancer 
and ischaemic geart disease. Highly reactive molecules called free radicals can cause 
tissue damage by reacting with polyunsaturated fatty acid in cell membrane, 
nucleotides, DNA and critical sulfyhydral bonds in proteins.115 
 
 The extent of tissue damage is the result of imbalance between free radicals 
generated and antioxidants protective defense system. Literature data pointed out the 
indigenous natural antioxidants helps to prevent the deleterious outcome of oxidative 
stress. Thus an effort was taken to highlight the antioxidant potency of Azima 
tetracantha by DPPH assay.  All the 15 fractions were screened for its invitro 
antioxidant activity.  
 
DPPH Assay 
 DPPH is a stable free radical which produces deep purple colour by accepting 
proton from any proton donor substance and widely used to test free radical 
scavenging effect. DPPH become a stable diamagnetic molecule by accepting either 
an electron or proton.116 The reduction of DPPH molecule is determined by its 
decrease in the absorbance at 515nm due to colour change 
 
In vitro antioxidant activity (DPPH assay)117 
The effect of given samples on DPPH radical was estimated according to the 
procedure described by Von Gadow et al. (1997). Two ml of 6 ×10-5 M methonolic 
solution of DPPH were added to 50 µl of a methonolic solution (10 mg ml-1) of the 
sample. Absorbance measurements commenced immediately. The decrease of 
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absorbance at 515 nm was continuously recorded in a spectrophotometer for 16 min at 
room temperature. Methanolic solutions of pure compound (Vitamin C) were tested at 
1 mg/ml concentration. The scavenging effect (decrease of absorbance at 515 nm) 
was plotted against the time and the percentage of DPPH radical scavenging ability of 
the sample was calculated from the absorbance value at the end of 16 min duration as 
follows., 
 
All determinations were performed in triplicate. The percentage inhibition of 
the DPPH radical by the samples was calculated according to the formula.118 
IP = [(AC(0)- AA(t)/ AC(0))] × 100 
Where AC(0) is the absorbance of the control at t = 0 min 
AA(t) is the absorbance of the antioxidants at t = 16 min. 
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8.1.5. SPECTRAL STUDIES 
The bioactive compounds isolated from the ethanolic extract of leaves of 
Azima tetracantha using Bioactivity guided isolation in Column chromatography 
were characterized by spectral studies. 
 
Ultra-Violet Spectroscopy119 
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or 
reflectance spectroscopy in the ultraviolet-visible spectral region. This means it uses 
light in the visible and adjacent (near-UV and near-infrared [NIR]) ranges. Molecules 
containing π-electrons or non-bonding electrons (n-electrons) can absorb the energy in 
the form of ultraviolet or visible light to excite these electrons to higher anti-bonding 
molecular orbitals. 
 
Fourier Transform Infrared Spectroscopy 
Infrared spectroscopy is the spectroscopy that deals with the infrared region of 
the electromagnetic spectrum, that is light with a longer wavelength and 
lower frequency than visible light. IR spectrum is considered as vibrational- rotational 
spectra. KBr pellet technique was used for solid compound and Nujol mull method 
was followed if the compound was liquid.  
 
 Infrared spectroscopy is a very useful technique in the preliminary stages of 
investigation of a compound, as it provides data regarding the presence of functional 
groups, such as hydroxyl, carbonyl of all kind (aldehydes, ketones, carboxylic acids, 
esters, lactones etc.) in different environments.120 
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Nuclear Magnetic Resonance Spectroscopy121 
NMR spectroscopy is a research technique that exploits 
the magnetic properties of certain atomic nuclei. It determines the physical and 
chemical properties of atoms or the molecules in which they are contained. It relies on 
the phenomenon of nuclear magnetic resonance and can provide detailed information 
about the structure, dynamics, reaction state, and chemical environment of molecules.  
Mass Spectroscopy122 
Mass Spectroscopy (MS) is an analytical technique that sorts ions based on 
their mass (or "weight"). Mass spectroscopy is used for chemical analysis and the 
spectra are used to determine the elemental or isotopic signature of a sample, the 
masses of particles and of molecules, and to elucidate the chemical structures of 
molecules, such as peptides and other chemical compounds. Mass spectroscopy works 
by ionizing chemical compounds to generate charged molecules or molecule 
fragments and measuring their mass-to-charge ratios. 
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Fig 13: Schematic representation of Bioactivity guided isolation of  
Azima tetracantha Lam. 
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8.2. RESULTS  
 Phytochemistry involves mainly secondary metabolites which are 
biosynthesized from plants. Most of the herbal medicines are sum of their constituents 
present in it. It is a distinct discipline which finds a remarkable position between 
natural product chemistry and plant biochemistry being closely related to both. 
EXTRACTION 
The percentage yield of various extracts of Leaves and stem of Azima 
tetracantha Lam were given in Table10. 
Table 10: Percentage yield of various extracts of Leaves and stem of  
Azima tetracantha Lam. 
S. No Extracts Parts Method of extraction Yield (%) 
1. Ethanol Leaf  
Soxhlet extraction 
16.7 
2. Hexane Leaf 1.8 
3. Ethanol Stem 2.3 
4. Hexane Stem 1.2 
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Qualitative phytochemical screening 
Preliminary phytochemical analyses of the extracts were done for the detection 
of various phytochemical constituents. All the extracts were showed the presence of a 
variety of phytochemicals. The preliminary phytochemical analysis of various extracts 
were reported in Table 11. 
 
Table 11:  Preliminary phytochemical test of various extracts of A. tetracantha. 
 
Phytochemical Test 
Ethanolic 
leaf extract 
Hexane leaf 
extract 
Ethanolic 
stem extract 
Hexane 
stem extract 
Alkaloids + - + - 
Carbohydrates - - - - 
Glycosides - - - - 
Protein & 
Aminoacids 
- - - - 
Flavonoids + + + + 
Tannins - - - - 
Steriods + + + + 
Oil + + + + 
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Fluorescence Analysis 
 Fluorescence characteristics of leaf, stem powder and various extracts were 
displayed in Table 12 and Table 13. 
Table 12: Fluorescence characteristics of leaves of Azima tetracantha 
Treatment Day light 
UV light 
254nm 365nm 
Powder 
Pale-brownish 
green 
Pale green Brown 
Powder + 1N NaOH (aqueous)  Yellowish green  Pale yellow  White  
Powder + 1N NaOH (alcoholic)  Pale green  Brownish green  Brownish green  
Powder + 1N Hydrochloric acid  Pale green  Brown  Black  
Powder + 50% Sulphuric acid  Pale green  Bluish green  Pale green  
Powder + 50% Nitric acid  Green  Yellowish 
green  
Black  
Powder + Picric acid  Dark yellow  Brown  Pale  brown  
Powder + Acetic acid  Pale green  Brownish green  Pale green  
Powder + Ferric chloride  Orange  Brown  Pale brown  
Powder +Con. Nitric acid  Brown  Brown  Black  
Powder + Nitric acid + 
Ammonia  
Green  Green  Black  
 
Table 13: Fluorescence characteristics of the extracts of Azima tetracantha 
Treatment Day light 
UV light 
254nm 365nm 
Ethanolic Leaf extract Green Greenish black Greenish black 
Hexane Leaf extract Green Dark green Green 
Ethanolic Stem extract Green Black Black 
Hexane Stem extract Green Black Black 
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Thin Layer Chromatography 
  Thin layer chromatography of hexane and ethanol extracts of leaves and stem 
were given in Table 14. 
Table 14: Thin layer chromatography of various extracts of Azima tetracantha 
S. No Extracts Solvent System No. of Spots Rf Value 
1.  
Ethanol- Leaf Hexane: Ethyl acetate (3.5:1.5) 8 
0.32, 0.47, 0.49 
0.53, 0.67, 0.75, 
0.78, 0.83 
2.  
Hexane- Leaf 
Ethyl acetate: ethanol: water 
(5:4:1) 
4 
0.45, 0.47, 0.52, 
0.69 
3.  
Ethanol- Stem Hexane: Ethyl acetate 5 
0.33, 0.49, 0.55, 
0.59, 0.61 
4.  
Hexane- Stem 
Ethyl acetate: ethanol: water 
(5:4:1) 
3 0.52, 0.71, 0.80 
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SELECTION OF ACTIVE EXTRACT 
Invitro anticancer activity (MTT Assay) 
The ethanolic leaf extract of Azima tetracantha showed inhibition of MCF-7 
cell lines in the ng range tested dose and other three extracts (hexane - leaf, stem and 
ethanolic stem) also displayed anticancer activities against MCF-7 cell line. Invitro 
anticancer activities of various extracts were carried out using MCF-7 Cell lines. The 
results were given in Table 15, 16,17 and 18. 
 
Table 15: Invitro anticancer activity of Ethanolic Leaf Extract  
Plant Extract Concentration Absorbance % Inhibition IC50 Value 
 
 
 
Ethanolic extract of  
Azima tetracantha 
Leaves 
1 ng 0.572 30.95 
40.809µg/ml 
10 ng 0.578 31.01 
100 ng 0.486 41.98 
1 µg 0.384 54.14 
10 µg 0.365 56.41 
100 µg 0.343 59.09 
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Fig 14: Invitro anticancer activity of Ethanolic Leaf Extract  
 
Fig 15: MCF-7 cell line inhibition of ethanolic extract of leaf in different 
concentrations. 
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Table 16: Invitro anticancer activity of Hexane Leaf Extract 
Plant Extract Concentration Absorbance % Inhibition IC50 Value 
 
 
Hexane extract of 
Azima tetracantha 
Leaves 
1 ng 0.675 19.43 
40.948µg/ml 
10 ng 0.578 31.01 
100 ng 0.481 42.58 
1 µg 0.409 51.16 
10 µg 0.313 62.61 
100 µg 0.282 66.31 
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Fig 16:  Invitro anticancer activity of Hexane Leaf Extract 
 
Fig 17: MCF-7 cell line inhibition of hexane extract of leaf in different 
concentrations. 
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Table 17: Invitro anticancer activity of Ethanol Stem Extract 
Plant Extract Concentration Absorbance % Inhibition IC50 Value 
 
 
 
Ethanolic extract 
of  
Azima tetracantha 
Stem 
1 ng 0.590 29.58  
 
 
 
 
 
41.226µg/ml 
10 ng 0.535 36.20 
100 ng 0.456 45.56 
1 µg 0.424 49.37 
10 µg 0.350 58.20 
100 µg 0.318 62.08 
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Fig 18: Invitro anticancer activity of Ethanol Stem Extract 
 
Fig 19: MCF-7 cell line inhibition of ethanolic extract of stem in different 
concentrations. 
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Table 18: Invitro anticancer activity of Hexane Stem Extract 
Plant Extract Concentration Absorbance % Inhibition IC50 Value 
 
 
Hexane extract of  
Azima tetracantha 
Stem 
1 ng 0.572 25.40 
 
 
 
 
 
 
 
36.384µg/ml 
10 ng 0.625 32.32 
100 ng 0.567 43.47 
1 µg 0.474 59.51 
10 µg 0.339 71.55 
100 µg 0.238 73.46 
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Fig 20: Invitro anticancer activity of Hexane Stem Extract 
 
 
Fig 21: MCF-7 cell line inhibition of hexane extract of stem in different 
concentrations. 
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BIOACTIVITY GUIDED ISOLATION 
Column chromatography 
Based on MTT assay, the active extract was selected and performed column 
chromatography using various solvents of increasing polarity. 45 fractions were 
eluted and pooled together based on its Rf value. Fractions obtained from column 
chromatography were shown in Table 19. 
Table 19: Bioactivity guided isolation of crude ethanolic extract of 
 Azima tetracantha Leaves 
Eluent Solvent ratio Fraction codes Fractions 
Hexane 100 F1 F1 
Hexane: Chloroform 95:5 F2-F6 F2 
Hexane: Chloroform 90:10 F7-F15 F3 
Hexane: Chloroform 80:20 IBC16 F4 
Hexane: Chloroform 50:50 F17-F26 F5 
Hexane: Chloroform 20:80 IBC27 F6 
Hexane: Chloroform 10:90 F28-F31 F7 
Chloroform 100 IBC32 F8 
Chloroform: Ethanol 95:5 F33-F35 F9 
Chloroform: Ethanol 90:10 F36 F10 
Chloroform: Ethanol 80:20 F37 F11 
Chloroform: Ethanol 50:50 F38 F12 
Chloroform: Ethanol 20:80 F39, F40 F13 
Chloroform: Ethanol 10:90 F41-F44 F14 
Ethanol 100 IBC45 F15 
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SELECTION OF ACTIVE FRACTION  
Invitro Antioxidant activity (By DPPH assay) 
Invitro antioxidant activity of all the fractions were done using DPPH assay 
and resulted in Table 20. 
Table 20: DPPH Scavenging Effect of various fractions  
Fractions Control Concentrations µg/ml 
 200 400 600 800 1000 
OD OD % OD % OD % OD % OD % 
Vit C 0.595 0.531 10.76 0.425 28.57 0.31 47.90 0.247 58.49 0.133 77.65 
F1 0.595 0.578 2.86 0.544 8.57 0.512 13.95 0.489 17.82 0.477 19.83 
F2 0.595 0.565 5.04 0.537 9.75 0.521 12.44 0.519 12.77 0.501 15.80 
F3 0.595 0.58 2.52 0.576 3.19 0.558 6.22 0.527 11.43 0.508 14.62 
F4 0.595 0.511 14.12 0.467 21.51 0.422 29.08 0.386 35.13 0.351 41.01 
F5 0.595 0.593 0.34 0.581 2.35 0.578 2.86 0.556 6.55 0.532 10.59 
F6 0.595 0.568 4.54 0.543 8.74 0.415 30.25 0.403 32.27 0.377 36.64 
F7 0.595 0.581 2.35 0.572 3.87 0.481 19.16 0.422 29.08 0.407 31.60 
F8 0.595 0.533 10.42 0.506 14.96 0.46 22.69 0.369 37.98 0.261 56.13 
F9 0.595 0.591 0.67 0.574 3.53 0.512 13.95 0.493 17.14 0.469 21.18 
F10 0.595 0.571 4.03 0.542 8.91 0.521 12.44 0.497 16.47 0.473 20.50 
F11 0.595 0.588 1.18 0.571 4.03 0.535 10.08 0.503 15.46 0.477 19.83 
F12 0.595 0.593 0.34 0.582 2.18 0.566 4.87 0.549 7.73 0.521 12.43 
F13 0.595 0.559 6.05 0.532 10.59 0.511 14.12 0.496 16.64 0.47 21.01 
F14 0.595 0.584 1.85 0.563 5.38 0.551 7.39 0.532 10.59 0.514 13.61 
F15 0.595 0.552 7.23 0.516 13.28 0.451 24.20 0.382 35.80 0.317 46.72 
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Fig 22: Graphical representation of percentage inhibition of DPPH of various fractions
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SPECTRAL STUDIES OF ISOLATED BIOACTIVE COMPOUNDS 
IBC 32 
 
N HN
HNN
H3C
OH
H3C
HO
O
H3C
HO
O
CH3
CH3
OH
CH3
 
7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoic 
acid 
IR (KBr, νmax) cm
-1 3698 (O-H stretching), 2924-2853 (C-H stretching), 
1711 (C=O stretching), 1641-1549 (N-H bending), 
1463 (C-C stretching), 1020 (C-N stretching). 
 
1H NMR (DMSO-D6) δ 2.03 (s, 1H), 2.12 (d, 1H), 2.24 (s, 1H), 3.32-3.33 (m, 
2H), 3.45 (s, 3H), 3.58 (s, 3H), 3.70 (t, 5H), 3.86 (s, 
4H), 3.98-4.03 (m, 2H), 4.13 (t, 1H), 4.34 (S, 1H), 5.26-
5.56 (m, 8H), 6.03-6.06 (m, 1H), 6.49 (t, 1H), 6.56-6.60 
(m, 1H), 6.75-6.77 (m,1H), 6.82 (d, 1H), 6.90 (t, 1H), 
7.49-7.52 (t,1H). 
 
13C NMR (DMSO-D6) δ 14.37, 15.56, 18.42, 22.51, 24.93, 25.82, 28.95, 29.10, 
29.29, 29.41, 29.90, 30.31, 31.59, 31.71, 31.99, 34.13, 
35.38, 35.67, 42.63, 50.01, 58.58, 79.56, 114.48, 
116.32, 132.11, 144.27, 175.02. 
 
MASS SPECTROSCOPY 598.87 (M+), 598(M+1), 108.00 (B). 
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IBC 32 
99 
 
IBC 16 
 
O
HO  
5,7,9(11)- androstatriene, 3-hydroxy-17-oxo 
 
IR (KBr, νmax) cm
-1 
 
3441 (O-H stretching), 2927-2854 (C-H stretching super 
imposed O-H stretching), 2727 (C-H stretching), 1734 
(C=O stretching for ketone), 1463(C=C stretching), 
1378 (C-H def. in CH3), 1247 (C-O stretching), 1010 (C-
O stretching for alcohol). 
 
1H NMR (DMSO-D6) δ 3.46-3.81 (m, 13H), 5.75 (s, 1H), 6.43-6.53 (m, 2H), 
6.58-6.62 (m, 1H), 6.67- 6.70 (m, 2H), 6.74-6.76 (m, 
2H), 6.80 (d, 2H), 6.90 (d, 1H). 
 
13C NMR (DMSO-D6) δ 29.58, 39.48, 39.65, 39.81, 39.98, 40.15, 40.31, 40.48, 
56.40, 108.52, 115.92, 122.00, 131.13, 149.23, 160.27 
 
MASS SPECTROSCOPY 283.74 (M+), 282.00(M+1), 148.67(B). 
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IBC 27 
 
N
HO
O
O
 
9-oximino-2,7-diethoxyfluorene 
IR (KBr, νmax) cm
-1 3429 (O-H stretching), 2954-2850 (C-H stretching super 
imposed O-H stretching), 2716 (C-H stretching), 2340 
(C=N stretching), 1738 (C=O stretching for ketone), 
1643-1462 (C=C stretching), 1377 (C-H def. in CH3), 
1259-1035 (C-O stretching). 
1H NMR (DMSO-D6) δ 3.01 (s, 6H), 6.78 (d, 2H), 7.24-7.25 (m, 1H), 7.45 (s, 
1H), 7.62 (d, 2H), 7.75 (s, 1H), 7.83-7.85 (m, 1H), 8.04-
8.05 (m, 1H). 
13C NMR (DMSO-D6) δ 39.48, 39.64, 39.81, 39.98, 40.15, 40.24, 40.31, 40.40, 
40.48, 123.08, 125.42, 131.22, 131.46. 
MASS SPECTROSCOPY 283.00 (M+), 282.00(M+1), 151.78(B). 
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IBC 45 
 
 
H
N
N
OH O
 
benzhydrazide,2-hydroxy-N2-(1-phenylpenylidene) 
IR (KBr, νmax) cm
-1 3429 (O-H stretching), 1636 (C=O stretching for 
ketone), 1456 (C=C stretching), 1384 (C-H def. in CH3), 
1238 (C-O stretching), 1074 (C-N stretching), 715 
(characteristic mono substituted benzene). 
1H NMR (DMSO-D6) δ 0.76 (d, 3H), 1.52 (s, 3H), 2.54-2.70 (m, 3H), 3.55 (d, 
1H), 4.02 (d, 1H), 7.20 (t, 2H), 7.27 (t, 5H), 7.38 (s, 4H). 
13C NMR (DMSO-D6) δ 47.09, 47.26, 47.43, 47.50, 47.51, 47.53, 47.54, 47.56, 
47.60, 47.77, 47.82, 47.83, 47.85, 47. 87, 47.89, 47.94, 
48.11. 
MASS SPECTROSCOPY 295.77 (M+), 294.22(M+1), 122.91(B). 
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8.3. DISCUSSION 
 Total ethanolic and hexane extracts were prepared from the leaves and stem of 
Azima tetracantha and the percentage yield was determined and tabulated. The 
ethanolic extract showed more percentage yield compared to other extracts. 
 
 Preliminary phytochemical analysis of the extracts was done for the detection 
of various phytochemical constituents. All the extracts were showed the presence of a 
variety of phytochemicals. Powders showed that, the presence of alkaloids, 
flavonoids, oils and steroids with various chemical reagents.  
 
Ethanolic extracts of leaf and stem showed the presence of alkaloids, 
flavonoids and steroids, hexane extracts of leaf and stem showed the presence of 
flavonoids and steroids. 
 
 Fluorescence properties of the powdered leaf, stem and various extracts were 
studied and the drug showed no fluorescence. 
 
 TLC studies were carried out on the extracts by the use of different mobile 
phases and detecting agents, to identify the nature of the extracts for further 
chromatographic studies. 
 
 All the extracts (ethanol and hexane of leaf and stem) were evaluated for 
invitro anticancer activity using MCF-7 cell line. It showed that, the ethanolic extract 
possess anticancer activity in the ng range.  
 
Based on MTT assay, the active extract was selected and performed Column 
chromatography using various solvents of increasing polarity. 45 fractions were 
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eluted and pooled together based on its Rf value obtained 15 fractions. The fractions 
were collected and dried under air current.  
 
All the 15 fractions were screened for their invitro antioxidant activity using 
DPPH assay. The fraction with highest antioxidant effect on DPPH was selected for 
invitro anticancer study.  
 
Fraction possessing isolated bioactive compounds such as IBC16, IBC27, 
IBC32 and IBC45 which displayed еffеctivе inhibition on DPPH in invitro anti-
oxidant activity were subjected to spectral analysis and with the help of the spectra, 
the proposed structures were elucidated.  
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CHAPTER 9 
PHARMACOLOGICAL STUDIES 
 
Pharmacological screening is essential to evaluate the efficacy and potency of 
the plant drug. Isolated bioactive compound was selected for the acute toxicity studies 
in animal to determine the toxicity of the compound and anticancer screening in 
various cell lines using MTT assay based on the inhibition of cell lines. 
9.1. MATERAIALS AND METHODS 
9.1.1. ACUTE TOXICITY STUDY123,124 
All the animal experiments have been carried out according to the 
internationally valid guidelines and they are approved by the “Institutional Animal 
Ethical Committee [IAEC] of Committee for the Purpose of Control and Supervision 
on Experimentation on Animals [CPCSEA]”. 
All the isolated bioactive compounds and extract which showed promising in-
vitro antioxidant activity were subjected to invivo acute toxicity studies in order to 
find out the toxicity induced mortality and other behavioral changes. 
The protocol for conducting the in vivo study in female adult Wister albino 
mice was approved by the Institutional Ethical Committee (ICE) of the Madras 
Medical College, Chennai - 600003, India. Animal CPCSEA Approval Number: 
05/243/CPCSEA, Dated: 9/3/16. 
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Materials 
 Acute toxicity studies were carried out by acute oral toxic class method 
(OECD guidelines, 423). 
 The animals used for acute toxicity were Swiss Albino mice (20-30 gm) of 
female sex, n=3/group, with one untreated control group. 
 The compounds showing in-vitro inhibitory activity on DPPH were selected 
for acute oral toxicity studies. The selected compound codes were IBC16, IBC 
27, IBC 32, IBC 45 and ethanolic extract (EAT). 
Experimental 
Acute oral toxicity studies 
The acute oral toxicity of the isolated bioactive compounds was performed by 
acute oral toxic class method (OECD guidelines, 423). In this method, the toxicity of 
the selected isolated bioactive compounds was tested by using a step wise procedure, 
each step using three mice of a single sex. Before the commencement of study, the 
animals were kept under fasting for a period of three to four hours. The animals are 
deprived of food (but not water should be withheld) during the period of study. 
Following the period of fasting, the animals were weighed and the isolated bioactive 
compounds were administered orally at a dose of 2000mg/kg/p.o. Animals were 
observed for any signs and symptoms of mortality and recorded for at least once 
during the first 30 min and from then for every 4 hrs it was observed in first 24 hrs 
and the animals are kept under observation for a period of 14 days. Careful 
observations were made at least twice a day for the effect on CNS, ANS, motor 
activity, salivation, skin coloration and other general signs of toxicity were also 
observed and recorded. 
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The animals were observed for the following gross observations  
 Effect on cental nervous system- Stimulation, depression. 
 Effect on respiration- Stimulation, depression, respiratory failure 
 Effect on locomotor system- Increase in motor activity, reduction in 
motor activity. 
 Effect on skin colour- Blanching, cyanosis, vasodilation 
 Effect on excretion- Salivation, lacrimation, urination. 
 Other effects- piloerection, tonic or clonic convulsioms, ataxia, death. 
 
Fig 23: OECD guidelines 
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9.1.2. IN VITRO ANTICANCER ACTIVITY (MTT ASSAY)113, 125 
Isolated bioactive compound used: IBC32 
Cell line used: MCF-7, A549 and HeLa cell lines 
Chemicals and reagents 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) 
invitrogen, USA. Acridine orange were obtained from Sigma, USA. All other fine 
chemicals were obtained from Sigma–Aldrich, St. Louis. 
Cell culture 
All the cells obtained from NCCS (National Centre For Cell Science, Pune) 
were cultured in Rose well Park Memorial Institute medium (RPMI), supplemented 
with 10% fetal bovine serum, penicillin/streptomycin (250 U/mL), gentamycin 
(100µg/mL) and amphotericin B (1mg/mL) were obtained from Sigma Chemicals, 
MO, USA. All cell cultures were maintained at 37◦C in a humidified atmosphere of 
5% CO2. Cells were allowed to grow to confluence over 24 hrs before use. 
Cell growth inhibition studies by MTT assay 
Cell viability was measured with the conventional MTT reduction assay. 
Briefly, the cells were seeded at a density of 5×103 cells/well in 96-well plates for 24 
hrs, in 200ul of RPMI with 10% FBS. Then culture supernatant was removed and 
RPMI containing various concentrations of test compound was added and incubated 
for 48 hrs. After treatment cells were incubated with MTT (10µl, 5mg/mL) at 37 ◦C 
for 4 hrs and then with DMSO at room temperature for 1 hr. The plates were read at 
595nm on a scanning multi-well spectrophotometer. Data represented the mean values 
for six independent experiments.  
Cell viability (%) = Mean OD/Control OD x 100 
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9.2. RESULTS  
ACUTE ORAL TOXICITY 
Table 21: Acute oral toxicity of isolated bioactive compounds and extract 
Parameters IBC16 IBC27 IBC32 IBC45 EAT 
Aggressiveness Absent Absent Absent Absent Absent 
Alertness Present Present Present Present Present 
Convulsions Absent Absent Absent Absent Absent 
Corneal reflex Absent Absent Absent Absent Absent 
Gripping strength Absent Absent Absent Absent Absent 
Lacrimation Absent Absent Absent Absent Absent 
Pain response Present Present Present Present Present 
Pinna reflex Present Present Present Present Present 
Pupils Normal Normal Normal Normal Normal 
Respiration Normal Normal Normal Normal Normal 
Restlessness Present Present Present Present Present 
Righting reflex Absent Absent Absent Absent Absent 
Salivation  Absent Absent Absent Absent Absent 
Skin colour Normal Normal Normal Normal Normal 
Touch response Present Present Present Present Present 
Tremors Absent Absent Absent Absent Absent 
Urination Normal Normal Normal Normal Normal 
Writhing Absent Absent Absent Absent Absent 
Mortality Absent Absent Absent Absent Absent 
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The selected isolated bioactive compounds and extract (IBC16, IBC27, 
IBC32, IBC45 and EAT) had not shown any signs of toxicity up to 2000mg/kg body 
weight and was considered as safe (OECD-423 guidelines. 
From the acute toxicity studies the data revealed that, all the isolated bioactive 
compounds and extract proved to be non-toxic at tested 2000mg/kg b.w. dose level 
and well tolerated by the experimental animals. 
IN VITRO ANTICANCER ACTIVITY (MTT ASSAY) 
  The most effective isolated bioactive molecule was evaluated against various 
cell lines using MTT assay and reported the inhibition in Table 22. 
 
Table 22: In vitro anticancer activity of IBC32 on various cell lines 
Concentration (µg/ml) 
% Inhibition of various cell lines 
MCF-7 HeLa A549 
50 51.79 28.01 30.75 
100 55.62 35.06 33.72 
200 57.04 37.73 38.01 
400 57.54 46.41 46.41 
600 60.56 49.16 45.63 
800 62.61 51.68 52.16 
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Fig 24: Percentage inhibition of various cell lines of IBC32 
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9.3. DISCUSSION 
Acute toxicity studies of the isolated bioactive compounds (IBC16, IBC27, 
IBC32 and IBC45) and the corresponding extract revealed that, the drug was non- 
toxic upto the dose level of 2000mg/kg body weight. 
Four compounds (IBC16, IBC27, IBC32 and IBC458) which displayed 
еffеctivе inhibition on DPPH in invitro anti-oxidant activity were studied for their in-
vitro anticancer potential using various cell lines. It was found that compound IBC32 
was activе in in-vitro antioxidant assay, when compared to the other tested 
compounds.  
Fraction (IBC32) showed highest activity on DPPH, further evaluated for the 
invitro anticancer potential on various cell lines such as MCF-7, HeLa and A549 cell 
lines using MTT assay. It was concluded that, the isolated bioactive compound most 
effective on MCF-7 cell line when compared to other cancer cell lines. 
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CHAPTER 10 
DOCKING STUDIES 
Docking is the technique which envisages the preferred orientation of one 
molecule to a second when bound to each other to form a stable complex in three 
dimensional spaces. In cell biology, the function of proteins is a result of its 
interaction (i.e. docking) with other proteins as well as other molecular components. 
Thus the results of the docking are exceptionally beneficial in finding drugs which are 
effective against particular disease. Knowledge of the favored orientation in turn may 
be used to predict the strength of association or binding affinity between two 
molecules using scoring function.126 
10.1. DOCKING PRINCIPLE 
 The two main components that are important for docking studies are: 
 Secondary structure of our protein of interest. 
 Library of ligands from suitable data base. 
Docking tools are based on the search, algorithm and the scoring function. A 
search algorithm finds the best docking pose measured by the scoring function. A 
scoring function differentiates correct docking poses from incorrect ones. 
The quality of any docking results depends on the reasonable starting 
structures of both the protein and the ligand. The protein and ligand structures require 
preparation before docking in order to achieve the best docking results. 
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Types of Docking127 
Lock and Key or Rigid Docking- In rigid docking, both the internal geometry 
of the receptor and ligand is kept fixed and docking is performed.  
Induced Fit or Flexible Docking- an enumeration on the rotations of one of 
the molecules (usually smaller one) is performed. Every rotation the surface cell 
occupancy and energy is calculated; later the most optimum pose is selected.  
Molecular Docking by Argus Lab software  
Docking analysis of bioactive compounds i.e. ligands was carried out by 
Argus lab docking software. Docking virtually screen a set of compounds and predict 
the strongest binding capacity based on various scoring function. It explores ways in 
which two molecules such as ligand and receptor (protein) fit together and docks to 
each other well. The molecule binding to a receptor inhibits its function and thus acts 
as drug.  
Argus lab 4.0 distributed freely for windows platforms by planaria software. It 
is an introductory molecular modeling package with academics. Argus docking 
engine implementry in Argus lab approximates an exhaustive search method which is 
similar to DOCK and GLIDE. Flexible ligand docking is possible with Argus lab, 
where the ligand is described as torsion tree and grids are constructed that overlay the 
binding site. The accuracy of the Argus lab docking algorithm takes into account, the 
key features such as the nature of the binding site and the number of rotatable bonds 
to the ligand.  
Molegro molecular viewer: Molegro molecular viewer is an application which 
helps in analyzing the energies and interaction of the binding site.  
 
114 
 
 
Protein and Preparation 
A typical PDB (Protein Data Bank) structure file might be multimeric, which 
consists of heavy atoms, waters, cofactors, and metal ions. The structure usually has 
no information on bond orders, topologies, or formal atomic charges.  
The following course of actions is necessary to make a protein perfect for 
docking study: 
 Assigning ionization and tautomeric states of protein properly. (Side 
chains are reoriented when necessary and steric clashes are relieved). 
 Deleting all water molecules (except those coordinated to 
metals/bridged water molecules, if water molecules are retained then 
hydrogen’s should be added to them).  
 Adjusting the protonation of the protein, as this is crucial in the 
metalloprotein receptor sites. 
 Minimizing the protein to reorient side-chain hydroxyl groups and 
alleviating potential steric clashes present in the PDB structure.  
Ligand Preparation 
In order to get the best results, the ligands that are docked must be of good 
representations as they would appear in a protein-ligand complex. Most of the 
docking tools only modify the torsional internal coordinates of the ligand during 
docking; therefore the rest of the geometric parameters must be optimized 
beforehand.  
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               The structures subjected to docking tool must meet the following 
requirements: 
 They should be three-dimensional (3D).  
 They should have realistic bond lengths and bond angles.  
 They should each consist of a single molecule that has no covalent 
bonds to the receptor, with no accompanying fragments, such as 
counter ions and solvent molecules.  
 They should have all their hydrogen’s (filled valences).  
 They should have an appropriate protonation state for physiological pH 
values. 
Binding Site Analysis 
Knowledge of the structure and function of protein binding sites is the 
cornerstone of structure- based drug design and this requires understanding of both 
the location and physical properties of the binding site. In addition, the identification 
of small-molecule binding sites as modulators of protein-protein interactions has 
gained increasing interest. Furthermore, even when a validated binding site has been 
significant, it is often noteworthy to find additional potential binding sites where 
appropriate targeting could result in diverse biological effects. 
Scoring Methods 
Scoring of docked poses is however considered as one of the major challenges 
in the area of molecular docking. The objective of the scoring procedure is the 
identification of the correct binding pose by its lowest energy value, and the ranking 
of protein-ligand complexes according to their binding affinities.128-130 
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BIOLOGICAL TARGET 
There are various biosynthetic enzymes that are essential for the survival of 
the human and are considered as potential drug targets. Some of the targets are 
 
 Human PGK in complex with L-ADP, 3PG And TSA Aluminium 
tetrafluoride (2Y3I) 
 Cytochrome b5 core swab mutant (3OZZ) 
 Top BP1 BRCT4/5 domain (3UEN) 
 Human PGK1 3PG and tetrazosin (TZN ternary complex, 4O33) 
2Y3I 
2Y3I is a 2 chain structure with sequence from Homo sapiens. Defects in 
PGK1 are the cause of phosphoglycerate kinase 1 deficiency (PGK1D). It is a 
condition with a highly variable clinical phenotype that includes hemolytic anemia, 
rhabdomyolysis, myopathy and neurologic involvement. Patients can express one or 
more of these manifestations.131-133 
 
Fig 25: 3D Structure of 2Y3I 
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3OZZ  
3OZZ is a 1 chain structure with sequence from Bos taurus. Cytochrome b5 is 
a membrane bound hemoprotein which function as an electron carrier for several 
membrane bound oxygenases. 
 
Fig 26: 3D Structure of 3OZZ 
3UEN 
3UEN is a 1 chain structure with sequence from Human. It is required for 
DNA replication. It plays a role in the rescue of stalled replication forks and 
checkpoint control. It binds double-stranded DNA breaks and nicks as well as single-
stranded DNA. It recruits the SWI/SNF chromatin remodeling complex to E2F1-
responsive promoters. It also down-regulates E2F1 activity and inhibits E2F1-
dependent apoptosis during G1/S transition and after DNA damage.131,134-137 
 
 
 
 
 
 
Fig 27: 3D Structure of 3UEN 
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4O33  
4O33 is a 1 chain structure. Defects in PGK1 are the cause of 
phosphoglycerate kinase 1 deficiency (PGK1D). It is a condition with a highly 
variable clinical phenotype that includes hemolytic anemia, rhabdomyolysis, 
myopathy and neurologic involvement. Patients can express one or more of these 
manifestations.138 
 
Fig 28: 3D Structure of 4O33 
10.2. EXPERIMENTAL 
Ligand preparation  
 Draw the structure from chem. Sketch and save as MDL mol format.  
 Import the ligand into workspace of Argus lab.  
 Clean geometry → clean hybridization.  
 Select the ligand, right click on the mouse → make a group from the residues 
→ give name→ ligand→ OK.  
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Protein preparation 
Step 1:  
 Enter protein PDB-ID (2Y3I, 3OZZ, 3UEN, 4O33) in the protein data bank.  
 Go to download files and select pdb as text file.  
 Save the downloaded pdb text file to desktop.  
Step 2:  
 Open Argus lab file → open → Import pdb file from the desktop.  
 3D structure of the protein will appear in the workspace of Argus lab.  
 Left side of the screen shows molecular tree view.  
 Open pdb → open ‘Residues’ → open ‘Misc’.  
 From ‘Misc’ delete the inhibitor and hetero residues, do not delete cofactor.  
 Open water press shift, select all water molecules and delete.  
 Add hydrogen atoms.  
 Go to calculation on toolbar → energy by UFF method → start.  
 Save the prepared protein as *.agl file format in the desktop.  
Docking Parameters  
 Select calculation from the toolbar → Dock a ligand  
 ‘Argus Dock’ as the Docking engine  
 ‘Dock’ was selected as calculation type  
 ‘Flexible’ for the ligand  
 Ascore as the scoring function  
 Calculation size  
 Start docking  
 Save the Docked protein Ligand complex as Brookhaven pdb files (*.pdb)  
 
Visualization/ Interpretation of Docking  
Molegro molecular viewer will help in analyzing the energies and interaction 
of the binding.  
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10.3. RESULTS 
Table 23: 2D and energy minimized 3D structures of standard and IBC32 
Ligand 
code 
2D structure Energy minimized 3D structure 
 
PAC 
 
O
H3C
CH3
CH3
O
CH3
O
O
OH
O
CH3
OHOO
H3C
O
O
OH
NH
O
 
 
 
 
IBC32 
 
N HN
HNN
H3C
OH
H3C
HO
O
H3C
HO
O
CH3
CH3
OH
CH3
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Docking scores of compounds against multiple target enzymes 
Thе docking scorеs of the compounds rangеs from -12.79 to-8.92 kcal/mol on 
all thе targеt еnzymеs and wеrе summarizеd in Tablе 24, 25, 26 and 27. 
 
Table 24: Docking scores of compounds on PDB-ID 4O33 
 
Ligand 
code 
Structures PDB-ID 
Docking 
Scores 
(Kcal/mol) 
PAC 
O
H3C
CH3
CH3
O
CH3
O
O
OH
O
CH3
OHOO
H3C
O
O
OH
NH
O
 
4O33 
-11.0293 
IBC32 
N HN
HNN
H3C
OH
H3C
HO
O
H3C
HO
O
CH3
CH3
OH
CH3
 
-11.0687 
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Fig 29: Paclitaxel docked with PDB-ID 4O33 and its interactions 
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Fig 30: IBC32 docked with PDB-ID 4O33 and its interactions 
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Table 25: Docking scores of compounds on PDB-ID 2Y3I 
 
Ligand 
code 
Structures PDB-ID 
Docking 
Scores 
(kcal/mol) 
PAC 
O
H3C
CH3
CH3
O
CH3
O
O
OH
O
CH3
OHOO
H3C
O
O
OH
NH
O
 
2Y3I 
-12.7911 
IBC32 
N HN
HNN
H3C
OH
H3C
HO
O
H3C
HO
O
CH3
CH3
OH
CH3
 
-10.7869 
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Fig 31: Paclitaxel docked with PDB-ID 2Y3I and its interactions 
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Fig 32: IBC32 docked with PDB-ID 2Y3I and its interactions 
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Table 26: Docking scores of compounds on PDB-ID 3UEN 
 
Ligand 
code 
Structures PDB-ID 
Docking 
Scores 
(kcal/mol) 
PAC 
O
H3C
CH3
CH3
O
CH3
O
O
OH
O
CH3
OHOO
H3C
O
O
OH
NH
O
 
3UEN 
 
-11.1698 
IBC32 
N HN
HNN
H3C
OH
H3C
HO
O
H3C
HO
O
CH3
CH3
OH
CH3
 
-8.9262 
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Fig 33: Paclitaxel docked with PDB-ID 3UEN and its interactions 
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Fig 34: IBC32 docked with PDB-ID 3UEN and its interactions 
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Table 27: Docking scores of compounds on PDB-ID 3OZZ 
 
Ligand 
code 
Structures PDB-ID 
Docking 
Scores 
(kcal/mol) 
PAC 
 
O
H3C
CH3
CH3
O
CH3
O
O
OH
O
CH3
OHOO
H3C
O
O
OH
NH
O
 
3OZZ 
 
-11.6924 
IBC32 
 
N HN
HNN
H3C
OH
H3C
HO
O
H3C
HO
O
CH3
CH3
OH
CH3
 
-10.0192 
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Fig 35: Paclitaxel docked with PDB-ID 3OZZ and its interactions 
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Fig 36: IBC32 docked with PDB-ID 3ZOZ and its interactions 
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10.4. DISCUSSION 
CADD ϲomputational tools and softwares are used to simulate drug reϲeptor 
interaϲtions. Computational drug disϲovery helps sϲientists to get an insight into the 
drug- reϲeptor interaϲtions and also helps to reduϲe the time and ϲost. 
 
The isolated bioactive compound was prеdictеd to bе еffеctivе against cancer 
through computational studiеs. This was achiеvеd by thе molеcular docking studiеs 
against thе targеt еnzymеs such as (PDB ID- 4O33, 2Y3I, 3UEN, 3ZOZ) of cancer. 
IBC 32 scored-11.0687kcal/cal when docked with PDB-ID 4O33 whereas the 
standard (Paclitaxel) scored -11.0293kcal/mol. Docking of IBC32 on other enzymes 
(PDB-ID 2Y3I, 3UEN and 3OZZ) also showed relatively nearer scores with that of 
standard. 
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CHAPTER 11 
SUMMARY AND CONCLUSION 
 The thesis entitled “Evaluation of anticancer potential of leaves and stem of 
Azima tetracantha Lam” deals with pharmacognostical, phytochemical, toxicological 
and pharmacological investigations of Azima tetracantha Lam. A thorough literature 
survey revealed that Azima tetracantha highlighted for its valuable phytochemicals 
(azimine, azcarpaine and carpaine) and has an important role in antidiabetic, 
anticancer and hepatoprotective studies. This work was designed for the first time to 
notice isolation, characterization and docking of isolated bioactive compounds present 
in it and to establish its folklore claim on anticancer activity of the plant. 
 
 Recently, there is a progressive interest for natural antioxidant discovery for 
two valid reasons. 1. Epidemical and clinical evidences heighted the importance of 
fruits and vegetables in controlling chronic disease like cancer, 2. Phytochemicals are 
safer than synthetic chemicals. 
 The pharmacognostical evaluation of a species makes a valuable tool for the 
identification of the plant Azima tetracantha. Morphological study has provided a 
characteristic identity of the plant which was pale green colored, branchlets is terete 
or quadrangular. 
The various distinguishing features observed through anatomical studies. The 
transverse section of the leaf showed dorsiventral nature and there was a distinction 
between upper and lower side of the leaf surface. 
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 The powder microscopical examination of leaves exhibit the presence of 
parenchyma, sclerenchyma, trichomes, fibers, stomata, crystal sheath and xylem 
vessels and stem powder showed the presence of epidermis, fibres, pigments and 
xylem vessels.  
Quantitative microscopic data can be helpful in the determination of the 
authenticity of the plant. Various physicochemical parameters such as ash values, 
extractive values, loss on drying and foreign organic matter were found to substantiate 
its standard. 
 The qualitative preliminary phytochemical screening was performed to detect 
the nature of phytoconstituents present in it. The ethanolic extract showed the 
presence of alkaloids, steroids, flavonoids etc. and its hexane extract showed the 
presence of flavonoids and alkaloids. 
 Fluorescence properties of the powdered leaf, stem and various extracts were 
studied and the drug showed no fluorescence. 
 Thin layer chromatography of various extracts was carried out for the 
identification of the nature of the extracts for further chromatography studies by the 
use of different mobile phases and detecting agents. 
 Any significant deviation in the percentage of any parameters reported in this 
work may indicate adulteration (or) substitution in the drug. In this mineral analysis, 
presence of calcium, ron, sodium and potassium added its nutritional value and may 
be utilized as nutritional supplements in mineral deficiency disorder. The 
pharmacognostical and phytochemical details evolved from Azima tetracantha would 
help to fix up its standard and its adulterant/ substitution from other related species. 
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 The pharmacological studies revealed that the extracts showed significant 
anticancer property. In MTT assay method, ethanolic extract showed inhibition of 
MCF-7 cell line in the ng range. Hence the ethanolic extract was packed in column to 
scrutinize the phytoconstituents present in it. 
45 fractions were eluted and TLC analysis was carried out. Based on Rf value, 
the samples are pooled together and get 15 fractions. 
All the 15 fractions were screened for its invitro antioxidant activity using 
DPPH assay. The fraction with highest antioxidant effect on DPPH was selected for 
invitro anticancer study. Fraction possessing isolated bioactive compounds such as 
IBC16, IBC27, IBC32 and IBC45 which displayed еffеctivе inhibition of DPPH in 
invitro anti-oxidant activity were subjected to spectral analysis and with the help of 
the spectra, the proposed structures were elucidated.  
 
The spectral data confirms the presence of various phytoconstituents in 
ethanolic extract and the chemical name of the compounds 1, 2, 3 and 4 were 
identified as 7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-
dipropanoic acid, 9-oximino-2,7-diethoxyfluorene, 5,7,9(11)- androstatriene, 3-
hydroxy-17-oxo and benzhydrazide,2-hydroxy-N2-(1-phenylpenylidene) respectively. 
All the compounds were structurally elucidated and the compound one was 
identified and confirmed as “Hematoporphyrin”. This compound was isolated from 
Azima tetracantha for the first time.  
In acute toxicity studies (OECD guidelines 423), the extract and isolated 
bioactive compounds did not produce any significant changes in body weight and 
were free of toxicity. 
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Four compounds (IBC16, IBC27, IBC32 and IBC45) which displayed 
еffеctivе inhibition on DPPH in invitro anti-oxidant activity were studied for their 
invitro anticancer potential using various cell lines. It was found that compound 
IBC32 was activе in invitro antioxidant assay, when compared to the other tested 
compounds. 
 
The isolated bioactive molecule (IBC32) showed highest activity on DPPH, 
further evaluated for the invitro anticancer potential on various cell lines such as 
MCF-7, HeLa and A549 cell lines using MTT assay. It was concluded that, the 
isolated bioactive compound most effective on MCF-7 cell line when compared to 
that of other cancer cell lines. 
 
Finally, the docking study of the compound was performed by Argus lab 4.0 
software and the result concluded that has good binding interaction with biomarker 
enzyme and proved for its anticancer activity in molecular modeling study. It was also 
interesting to notice that, thе compound IBC32 showed good docking scores when 
compared to standard paclitaxel. 
 
 This scientific study concluded that the plant Azima tetracantha and its 
isolated bioactive compound (IBC32) have potent anticancer activity. Further 
research work has to be carried out for the formulation of isolated bioactive 
compound. Finally, it has to be screened for preclinical and clinical studies against 
cancer. 
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ABSTRACT 
Plants have played a central role in the prevention and treatment of diseases since prehistoric times. In 
recent years, there has been growing interest in the study of medicinal plants and their extensive use in 
different countries. However, today it is essential to pay for the scientific proof as to whether it is rational to 
use a plant or its active principles. Hence the present communication constitutes a review with adequate 
information on the medicinal properties, ethno medicinal uses, phytochemistry, and pharmacological 
activities of an Indian medicinal plant, Azima tetracantha Lam belonging to the family of Salvadoraceae. A 
wide range of phytochemical constituents have been isolated from A. tetracantha Lam which possesses 
activities like as stimulant, expectorant, antispasmodic, analgesic, anti-inflammatory, anti-ulcer, anti-
diarrhoeal, anti-microbial, hepatoprotective, nephroprotective, hypoglycemic and hyperlipidemic activities. 
Hence, extracts of Azima tetracantha could form one of the best options for developing novel natural 
medicine. 
KEYWORDS: Azima tetracantha Lam, Salvadoraceae, Sung-ilai, Azimine etc. 
INTRODUCTION
 In India treating specific ailments by the use of 
the different parts of several medicinal plants has been in 
vogue from ancient times. The indigenous system of 
medicines namely Ayurvedic, Siddha and Unani has been 
in subsistence for several centuries. Some drugs from 
Ayurveda approaching modern diseases, have already 
reached the market place1. It is estimated that nearly 
70000 plant species have been used for medicinal 
purposes. India recognizes more than 2500 plant species 
having medicinal value, Sri Lanka around 1400 and 
Nepal around 7002. About 40% of doctors’ especially in 
India and in China have reverted to increasing use of 
indigenous drugs and natural medicines3,4. The World 
Health Organization (WHO) estimates that about 80% of 
the populations living in the developing countries rely 
almost exclusively on traditional medicines for their 
primary health care needs.  
 Azima tetracantha Lam (Family: Salvadoraceae) 
plays a major role in the medicinal properties. The plant 
parts of Azima tetracantha such as roots, leaves, fruits 
and stems are used traditionally to treat various ailments 
and possesses activities like stimulant, expectorant, 
antispasmodic, analgesic, anti-inflammatory, anti-ulcer, 
anti-diarrhoeal, anti-microbial, hepatoprotective, 
nephroprotective, hypoglycemic and hyperlipidemic 
activities5. This review provides the botany, 
morphological character, geographical distribution, 
medicinal values, physicochemical characters, 
phytochemical characters and pharmacological activities 
of Azima tetracantha. 
 
Synonyms 
 Synonyms of Azima tetracantha includes 
Monetia barlerioides L’Herit., Azima nova J. F. Gmel., 
Kandena spinosa Rafin., Monetia angustifolia Boj. Ex A. 
DC., Monetia tetracantha (Lam.) Salisb. It is also called as 
“kundali” in Ayurveda, “mulchangan” in Siddha6. 
Scientific Classification7 
The scientific classification of A. tetracantha is 
demonstrated as follows: 
Kingdom: Plantae, Phylum: Tracheophyta, Class: 
Magnoliopsida, Order: Capparales, Family: 
Salvadoraceae, Genus: Azima, Species: Azima tetracantha 
lam. 
Vernacular Names8 
The vernacular names of A. tetracantha are described as 
follows: 
Sanskrit: Kundali, Hindi: Kanta- gur-kamai, Malayalam: 
Essanku, Sankukuppi, English: Bee sting bush, Fire thorn, 
Needle bush, Tamil: Sung-ilai, Ichanka 
Description9 
 Azima tetracantha is a perennial shrub growing 
upto 3m in hot, dry riverine scrub, particularly on 
alluvial or saline soil. The plant is dioecious, erect shrub 
with (1–)2 spines 0.5–5 cm long in each leaf axil, 
sometimes scandent with stems up to 8 m long; 
branchlets are terete or quadrangular, glabrous to 
densely hairy. The leaves of the plant are elliptical in 
shape and are rigid, pale green colored. The flowers are 
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small, greenish white (or) yellow colored, unisexual in 
axillary fascicles. Fruits are globular, white shiny. Seeds 
are compressed, circular. It occurs naturally in central, 
eastern and southern Africa as well as in the Indian 
Ocean Islands, and extends through Arabia to tropical 
Asia. 
Chemical Constituents10 
Table1: The chemical constituents present in Azima tetracantha 
Class Chemical Constituents 
Glucosinolates and glucosinolate derived compounds 3- indolylmethylglucosinolate 
N- hydroxyl- 3- indolylmethyl- glucosinolate 
N- methoxy- 3- indolylmethyl- glucosinolate 
Neoascorbigen  
Dimeric piperidine alkaloids Azimine 
Azcarpaine 
Carpaine 
Medicinal Importance of A. tetracantha 
  Azima tetracantha is a potent diuretic to treat rheumatism, dropsy, dyspepsia, chronic diarrhorea; it is used as 
stimulant tonic after child birth. A. tetracantha is used to treat cough, phthisis, asthma, small pox and diarrhorea. 
Rheumatism has been cured by its leaves, root and root bark5. 
Traditional Uses 
  Traditionally, root used as diuretic. In Siddha, root is used in the treatment for dropsy and rheumatism. Leaves 
are used as stimulant, expectorant and antispasmodic. It is also used in cough and asthma. Bark is used as antiperiodic, 
astringent and expectorant. In western India, juice of the leaves is applied as ear drops against earache and crushed 
leaves are placed on painful teeth. In India and Sri Lanka the root, root bark and leaves were administered with food as 
a remedy for rheumatism, dropsy, dyspepsia, chronic diarrhea and is considered as stimulant tonic and given to 
pubertal women immediately after confinement11,12. Locally, the traditional healers from Tirunelveli district of 
Tamilnadu use the root bark (paste with buttermilk) as potent remedy for jaundice. 
MACROSCOPIC CHARACTERS13 
Table 2: Preliminary macroscopical characters of Azima tetracantha 
Azima tetracantha Characters 
 
 
 
Leaf structures 
Nature Decussately opposite 
Shape Blade elliptical-oblong to ovate-oblong or orbicular 
Dimensions 1.5–5.5 cm × 0.5–4.5 cm 
Stipules Absent/ rudimentary 
Leaf margin Simple and entire 
Leaf apex Mucronate 
Leaf base Pinnately veined with one pair of lateral veins 
 
 
Flower structures 
Petals shape Linear oblong to oblong 
Length  2- 4 mm 
Lobes Triangular 
Male flowers Stamens inserted at the base 
Female flowers Staminoids and superior ovary 
Fruit structures Nature Globose berry 
Dimension 0.5- 1cm diameter 
MICROSCOPIC CHARACTERS13 
Table 3: Microscopical characters of Azima tetracantha 
Azima tetracantha Characters 
 
 
 
 
Leaf 
structures 
Transverse section Dorsiventral nature 
Midrib Flat and hemispherical 
Cuticle Thin, rectangular and prominent 
Vascular bundle Single and abaxial arc shaped phloem 
Sclerenchyma Absent 
Lamina 230mm thick 
Trichomes Absent 
Abaxial epidermis Stomatiferrous 
Epidermal tissues Stomata and epidermal cells 
Stomata Anisocytic 
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Petiole (basal and upper part) 1.15µm diameter, circular 
 
 
 
Stem 
structures 
Young stem 1.5mm thick, consists of a distinct continuous epidermis, 
cortex, vascular cylinder and pith 
Epidermal cells Squarish or rectangular 
Cuticle Thick  
Stomata Frequently seen 
Cortex 150mm width, consists of chlorenchyma and parenchyma 
Pith Wide, homogenous and parenchymatous.  
Vascular cylinder 29 discrete vascular bundles 
Root bark 
structures 
Periderm No deep fissures and contains homogenous phellan cells  
Pseudocortex Inner to the periderm, is a wide parenchymatous zone 
Secondary phloem It consists of Collapsed and Non- collapsed phloem 
PHARMACOLOGICAL ACTIVITIES 
Antimicrobial activity of Azima tetracantha Lam 
 Antimicrobial activity of different extracts of 
Azima tetracantha root was carried out by Vinoth and 
Manivasagaperumal, in 2015 against human pathogenic 
bacterial and fungal strains using disc diffusion method. 
The study concluded that methanolic root extract of 
Azima tetracantha had a potential antimicrobial activity 
against all the microorganisms tested14. The invitro 
antimicrobial activity of Azima tetracantha leaves was 
studied by Vinoth et al., in 2014 against various human 
bacterial and fungal pathogens using disc diffusion 
method. Phytochemical analysis of Azima tetracantha 
leaf extracts revealed that the extracts justify the 
presence of secondary metabolites and their liability for 
the activity15. Antibacterial activity of phytocompound 
separation from alkaloids, flavonoids and sterol were 
tested against Staphylococcus aureus, Bacillus subtilis, 
Klebsiella pneumoniae, Pseudomonas aeruginosa and 
E.coli by Gowthami et al., in 2012. The sterols compound 
exhibited maximum activity when compared with 
alkaloids and flavonoids16. The antimicrobial potential of 
leaves of Azima tetracantha was checked against the 
clinical pathogens by Hema et al., in 2012 using agar well 
diffusion method. Antimicrobial activities of five solvent 
extracts (ethanol, methanol, acetone, chloroform and 
distilled water) were tested against seven clinical 
pathogens such as Staphylococcus aureus (Pus), Klebsiella 
sp. (Sputum), Escherichia coli (Urine), Pseudomonas sp. 
(Pus), Enterococci sp. (Urine), Serratia sp. (Sputum) and 
Proteus sp. (Sputum). Among the five solvent extracts 
tested, ethanolic extracts of Azima showed superior 
activity against the pathogenic organisms17. The study 
based on the evaluation of the antifungal activity of 
Azima tetracantha extracts and isolated compound 
(friedelin) against fungi was carried out by 
Duraipandiyan et al., in 2010 using the micro dilution 
method. The study concluded that extracts have 
antifungal activity and strongly suggests that isolated 
compound friedelin as an antifungal agent18. The study 
designed by Maruthi et al., in 2010 evaluated the 
anthelmintic and antimicrobial activities of Azima 
tetracantha. The results revealed that, alcoholic extract 
was found to possess antibacterial and antifungal 
activities while chloroform extract showed only 
antibacterial activity19. 
 
Antioxidant and free radical scavenging activities of 
Azima tetracantha Lam 
 Phenolic compounds are classic active oxygen 
scavengers in plants and are acknowledged to contribute 
directly to antioxidant action. The hydroxyl groups of the 
phenolic compounds confer the scavenging ability of the 
plant (Yildrim)20. The different extracts of A. tetracantha 
root were studied for antioxidant potential by Vinoth et 
al., in 2015 by using different invitro assays such as 
inhibition of DPPH, ABTS, hydroxyl radical and 
superoxide anions. The total phenolic contents and ferric 
reducing antioxidant power of the extracts were also 
determined by using standard phytochemical reaction 
methods. The results revealed that the different extracts 
of A. tetracantha root showed a good dose dependent 
free radical scavenging activity in all the models. Ferric 
reducing antioxidant power was found to be increased 
with increase in extracts concentrations21. Muthuswamy 
et al., in 2012 performed an antioxidant study of 
methanol and ethyl acetate leaf extract of Azima 
tetracantha Lam. The study designed against the 
inhibition of the LPO, DPPH, superoxide anion, hydroxyl 
radical. The result indicated that the ethyl acetate extract 
posses moderate activity when compared with that of the 
standards22. In an antioxidant study of leaf extracts of 
Azima tetracantha Lam done by Gayathri G et al., in 2011, 
the reducing capacity improved with the increasing 
concentration of the extract. This showed that the 
antioxidant compounds can react with free radical to 
convert them to more stable products and thereby 
terminate radical chain reactions. The report concluded 
that the leaves of A. tetracantha were proved to be good 
source of natural phenolic compounds23. The study 
designed by Thendral Hepsibha et al., in 2010 evaluated 
antioxidant and free radical scavenging activities of 
Azima tetracantha. Lam. leaf extracts. The result 
suggested that the methanolic extract of the A. 
tetracantha leaves showed better free radical capacity 
against different reactive oxygen /nitrogen species, 
among other extracts although with different efficiencies. 
The study concluded that the high content of 
antioxidants like phenolic compounds, flavonoids and 
vitamins found in these extracts, may impart health 
benefits by combating the free radicals in synergistic 
manner along with other compounds and thus constitute 
part of the basis for the ethno pharmacological claim24. 
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Anti- inflammatory, Analgesic and Antipyretic effects 
from Azima tetracantha Lam 
 The study designed by Antonisamy et al., in 2011 
evaluated the anti-inflammatory, analgesic and anti-
pyretic effects of friedelin. The effects of friedelin on 
inflammation were studied by using carrageenan-
induced hind paw oedema, croton oil-induced ear 
oedema, acetic acid-induced vascular permeability, 
cotton pellet-induced granuloma and adjuvant-induced 
arthritis. The analgesic effect of friedelin was evaluated 
using the acetic acid-induced abdominal constriction 
response, formalin induced paw licking response and the 
hot-plate test. The antipyretic effect of friedelin was 
evaluated using the yeast induced hyperthermia test in 
rats. In the acute phase of inflammation, maximum 
inhibitions were prominent with friedelin in 
carrageenan-induced paw oedema and croton oil-
induced ear oedema. Administration of friedelin notably 
decreased the formation of granuloma tissue. Friedelin 
also produced considerable analgesic activity in the 
acetic acid-induced abdominal constriction response and 
formalin-induced paw licking response. Treatment with 
friedelin showed a noteworthy dose-dependent 
reduction in pyrexia in rats25. The anti-inflammatory 
activity of Salacia oblonga root bark powder and Azima 
tetracantha leaf powder was assayed in male albino rats 
using carrageenan-induced rat paw oedema (acute 
inflammation) and cotton pellet granuloma (chronic 
inflammation) methods by Syed Ismail et al., in 1997. The 
study concluded that both the crude drugs were 
optimally active at a dose of 1000 mg/kg. In the cotton 
pellet granuloma assay, both the crude drugs were able 
to suppress the transudative, exudative and proliferative 
components of chronic inflammation26. 
Antinephrotoxic potential of Azima tetracantha Lam 
 The biochemical markers of nephrotoxicity are 
urea, creatinine and GGT. Their levels are significantly 
elevated in nephrotoxic situation due to metal induced 
damage to nephrons. In nephrotoxicity, the serum urea 
and creatinine accumulates because the rate of serum 
urea and creatinine production exceeds the rate of 
clearance due to defects in the glomerular filteration 
rate. The study designed by Konda et al., in 2015 
evaluated the nephroprotective effect of root extract of 
Azima tetracantha in glycerol-induced acute renal failure 
in Wistar albino rats. The study report suggested that 
there was a considerable improvement in biochemical 
parameters and histopathological changes when 
compared with glycerol treated group. The antioxidant 
activity of the root extract of A. tetracantha was tested 
invitro and invivo. Both invitro and invivo assays showed 
significant antioxidant activity and due to this, the 
nephroprotective effect of A. tetracantha in glycerol-
induced acute renal failure was estabilished6. The results 
of the study done by Manikandaselvi et al., in 2012 
indicated the significant elevation in the levels of urea, 
GGT and creatinine in ferrous sulphate induced group 
compared to control. After treatment with Azima 
tetracantha Lam there was a significant decrease in the 
levels near to normal compared to ferrous sulphate 
induced group. The study concluded that the 
nephroprotection could be attained due to its antioxidant 
and free radical scavenging activity27. 
Hepatoprotective activities of Azima tetracantha Lam 
 Hepatotoxicity induced in albino rats by ferrous 
sulphate and their hepatoprotective effect was studied 
by using aqueous extracts of Azima tetracantha by 
Soumya and Nagarajan in 2014. Aqueous extracts of 
Azima tetracantha showed a significant reduction in all 
the biochemical parameters of liver damage glucose, 
protein, bilirubin, cholesterol, ALP, SOD, CAT, Vitamin E, 
TBARS, Albumin and globulin elevated by ferrous 
sulphate28. Antioxidant, free radical scavenging and liver 
protective effects of friedelin isolated from Azima 
tetracantha Lam leaves were performed by Sunil et al., in 
2013. The report in the study indicated that friedelin 
restored the levels of SGOT, SGPT, LDH, SOD, catalase 
(CAT), reduced glutathione (GSH) and glutathione 
peroxidase (GPx) and showed liver protection, 
comparable to the standard silymarin29. A study report 
by Sambasivam et al., in 2013 on hepatoprotective 
potential of Azima tetracantha and Tribulus terrestris on 
ferrous sulfate-induced toxicity in rat revealed that the 
hydroalcoholic extract of leaf powder of Azima 
tetracantha and the fruit powder of Tribulus terrestris 
retrieved the liver parameters to usual level and 
possesses significant hepatoprotective activity30. A study 
done by Balakrishnan et al., in 2012 reported that the 
ethanol (50%) extract of Azima tetracantha Lam. (EEAT) 
root bark afforded significant protection against carbon 
tetrachloride (CCl4) induced hepatocellular injury. The 
report also revealed that the normal liver cellular 
architecture was retained when the liver sections of the 
rats treated with EEAT root bark extract for 7 days there 
by further confirming the intoxicating hepatoprotective 
effect of EEAT root bark31. Reports documented by 
Nargis et al., in 2011 revealed that the rats treated with 
ethanolic extract of A. tetracantha showed a significant 
reduction in all the five-biochemical parameters of liver 
damage (AST, ALT, ALP, ACP and total bilirubin) elevated 
by carbon tetrachloride32. 
Antiulcer Activity of Azima tetracantha Lam 
 Antonisamy et al., in 2015 recorded the 
protective effects of friedelin isolated from Azima 
tetracantha Lam against ethanol-induced gastric ulcer in 
rats. The result from the study showed that the friedelin 
isolated from the hexane extract of leaves of Azima 
tetracantha protected from ethanol caused severe gastric 
damage and suggested that friedelin could be a new 
effective natural gastroprotective tool against gastric 
ulcer33. EEAT showed notable dose-dependent ulcer 
protective effect against cold restraint stress and aspirin 
plus pylorus ligation induced gastric ulcers on the study 
performed by Muthusamy et al., in 2009. The conclusion 
of the study stated that the gastro duodenal ulcer 
protecting effect of EEAT may be due to its predominant 
effect on the mucosal defensive factors rather than 
offensive factors34. 
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PHYTOCHEMISTRY 
 The preliminary phytochemical screening 
carried out on various extracts of A. tetracantha revealed 
the presence of phytoconstituents such as alkaloids, 
flavonoids, glycosides, steroids, carbohydrates, tannins, 
proteins and aminoacids. Other compounds such as 
friedelin, lupeol, glutinol and β- sitosterol have also been 
reported in A. tetracantha. 
Physicochemical analysis13 
 The physicochemical characters such as 
organoleptic characters, fluorescence and the percentage 
of total ash, acid-insoluble ash, water-soluble ash and 
alkalinity of water soluble ash values of the powdered 
stem bark of A.tetracantha were evaluated. 
Organoleptic characters of A.tetracantha stem bark 
powder 
Colour: Pale brownish yellow  
Appearance: Coarse powder 
Odour: No characteristic odour 
Taste: No characteristic taste 
Table 4: Determination of consistency of A. tetracantha 
stem bark powder 
Treatment Observation 
Powder treated with water Non-sticky 
Powder shaken with water Honey comb like 
froth 
Powder treated with 5% 
aqueous sodium 
hydroxide Pale 
yellow 
Powder treated with 60% 
aqueous sulphuric acid 
Reddish brown 
Powder pressed between filter 
paper for 24 hours 
No oil stain 
Table 5: Fluorescence characteristics of A.tetracantha stem bark powder 
Treatment Day light 
 
UV light 
254nm 365nm 
Powder Pale-brownish yellow Pale green Brown 
Powder + 1N NaOH (aqueous) Pale yellow Pale yellow Black 
Powder + 1N NaOH (alcoholic) Orange Yellowish green Black 
Powder + 1N Hydrochloric acid Pale yellow Black Black 
Powder + 50% Sulphuric acid Reddish brown Dark brown Black 
Powder + 50% Nitric acid Orange Yellowish green Black 
Powder + Picric acid Yellow Green Black 
Powder + Acetic acid Brown No visible colour Black 
Powder + Ferric chloride Orange Green Black 
Powder +Con. Nitric acid Brown Green Black 
Powder + Nitric acid + Ammonia Reddish orange with precipitate Green Black 
Table 6: Ash values of A.tetracantha stem bark powder 
Physicochemical Constants Values 
Total ash 21.625% 
Water soluble ash 13.945% 
Alkalinity of water soluble ash 1.73ml 
Acid insoluble ash 0.665% 
Phytochemical test22 
Table 7: Preliminary phytochemical test of various extracts of A. tetracantha. 
Phytochemical Test Pet. Ether extract Ethylacetate Extract Methanol Extract 
Alkaloids - + + 
Carbohydrates - - - 
Glycosides - - - 
Protein & Aminoacids - - - 
Flavonoids + + + 
Tannins - - - 
Steriods + + + 
Oil + + + 
 
 
Sundaresan Nandhini, Ramalingam Radha. Pharmacognosy of Azima Tetracantha: A Review 
 Available online at: http://ijapr.in  18 
Phytochemical structures35 
 The phytochemical constituents with their structures present in A. tetracantha are given in Fig. 1: 
Fig. 1: The phytochemical constituents with their structures present in A. tetracantha35 
 
CONCLUSION 
 The information summarized here is well- 
intentioned to serve as a reference tool to researchers in 
the field of ethanopharmacology of Azima tetracantha. 
Based upon the literature survey, it can be concluded 
that Azima tetracantha has been widely studied for its 
pharmacological activities. Science has always 
acknowledged the value of healing substances found in 
nature, such as digitalis, aspirin, penicillin, insulin, 
steroids etc. There is no doubt that valuable medicinal 
shrub, Azima tetracantha will be a treasure and will top 
the list of treasure hunters. Further research is needed to 
explore the unclaimed therapeutic effect of active 
compounds present in the shrub and the plausible 
molecular mechanisms of those active compounds. 
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ABSTRACT 
The present study deals with anticancer activity of Azima tetracantha. 
The leaves and stem of the plant material were extracted with hexane 
and ethanol using soxhlet extraction. Anticancer activities of various 
extracts were assayed with standard MTT colorimetric procedure 
against MCF-7 cell lines. From the analysis it was found that ethanolic 
leaf extract of Azima tetracantha showed MCF-7 cell line inhibition at 
ng range tested dose and other three extracts (hexane - leaf, stem and 
ethanolic stem) also displayed anticancer activities against MCF-7 cell 
line. Further work is in progress to evaluate the chemical constituents 
present in the extract. 
 
KEYWORDS: Azima tetracantha Lam., Antioxidant, Anticancer,  
MTT Assay, MCF-7 cell lines. 
 
INTRODUCTION 
The word „cancer‟ originated from ‘cancrum’ which is a Greek word for crab as it furnishes 
with claws on both sides of its body, so does the disease.
[1]
 Cancer is an abnormal growth of 
cells which tend to proliferate in an uncontrolled way and in some cases, to metastasize, 
invade and spread to distant sites of the body.
[2]
 Cancer is caused by both external factors 
(tobacco, chemicals, radiation and infectious organisms) and internal factors (inherited 
mutations, hormones, immune conditions and mutations that occur from metabolism).
[3,4]
 It 
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can be treated with surgery, radiation, chemotherapy, hormone therapy and biological 
therapy.
[5]
 Natural products have had a major impact on longevity and quality of life is in the 
chemotherapy of cancer. In fact, most major anticancer drugs are derived from plants or 
microorganisms. Examples include, Bleomycin, Doxorubicin, Daunorubicin, Vincristine, 
Mitomycin, Streptozocin, Paclitaxel (Taxol 
TM
), Irinotecan (a camptothecin derivative), 
Etoposide and Tenoposide (podophyllotoxin derivatives).
[6] 
 
Azima tetracantha Lam., is a unique folk medicinal plant known as Mulsangu in Tamil, 
belonging to the family “Salvadoraceae”, which has various medicinal properties like 
stimulant, antispasmodic, anti rheumatism, diuretic, anti inflammatory, anti microbial, 
hypoglycemic, antioxidant and hypolipidemic activity. It is also used in the treatment of 
cancer, dyspepsia and chronic diarrhoea.
[7,8]
 Phytochemical composition of the plant like 
alkaloids
[9]
, triterpenoids
[10]
 and flavonoids
[11] 
etc. were also reported. Clinical data showed 
that in the past there were herbs with anticancer property but the scientific validity of Azima 
tetracantha have not been established. Hence, the present study was designed to evaluate the 
anticancer activity of various extracts of leaves and stem of Azima tetracantha. 
 
MATERIALS AND METHODS 
Collection and identification of the Plant Material 
The plant materials (leaves and stem) of Azima tetracantha Lam., were collected from 
Vellore district, Tamilnadu, India. The collected plant materials were botanically identified 
and authenticated by the Botanist Dr. Aravind, National Institute of Siddha, Tambaram, 
Chennai. The herbarium specimen was prepared and deposited at Department of 
Pharmacognosy, College of Pharmacy, Madras Medical College, for future reference. 
 
Extraction of plant material 
Freshly harvested leaves and stem were air- dried at room temperature for a period for 2 
weeks. Dried materials were coarsely grounded and stored in an air- tight container. About 
200g of dried powdered leaves and stem were packed well in soxhlet apparatus and was 
subjected for hot extraction with hexane and ethanol (99.9%) at 18 hrs. The extract was 
filtered while hot and concentrated under Rotary vacuum evaporator in order to remove the 
solvent completely, dried and kept in a desiccator till further use. 
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IN VITRO ANTICANCER ACTIVITY 
Chemicals and reagents 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) invitrogen, USA. 
Acridine orange were obtained from Sigma, USA. All other fine chemicals were obtained 
from Sigma–Aldrich, St. Louis. 
 
Cell culture 
MCF 7 cells obtained from NCCS (National Centre For Cell Science, Pune) were cultured in 
Rose well Park Memorial Institute medium (RPMI), supplemented with 10% fetal bovine 
serum, penicillin/streptomycin (250 U/mL), gentamycin (100µg/mL) and amphotericin B 
(1mg/mL) were obtained from Sigma Chemicals, MO, USA. All cell cultures were 
maintained at 37◦C in a humidified atmosphere of 5% CO2. Cells were allowed to grow to 
confluence over 24 h before use. 
 
Cell growth inhibition studies by MTT assay
[12]
 
Cell viability was measured with the conventional MTT reduction assay. Briefly, MCF 7 
cells were seeded at a density of 5×10
3
 cells/well in 96-well plates for 24 h, in 200ul of RPMI 
with 10% FBS. Then culture supernatant was removed and RPMI containing various 
concentrations of test compound was added and incubated for 48 h. After treatment cells 
were incubated with MTT (10µl, 5mg/mL) at 37◦C for 4 h and then with DMSO at room 
temperature for 1h. The plates were read at 595nm on a scanning multi-well 
spectrophotometer. Data represented the mean values for six independent experiments.  
Cell viability (%) = Mean OD/Control OD x 100. 
 
RESULTS  
MCF-7 cell line inhibition of various extracts using MTT assay showed in Table 1 and Figure 
1 and its graphical representation showed in Figure 2. 
Table 1: In-vitro anticancer activity of the extracts of Azima tetracantha 
Concentration 
(µg/ml) 
MCF-7 Cell lines 
Ethanolic Leaf 
Extract 
Hexane Leaf 
Extract 
Ethanolic Stem 
Extract 
Hexane Stem 
Extract 
Control 4.29 4.29 4.29 4.29 
1ng 30.95 19.43 29.58 25.40 
10ng 31.01 31.01 36.20 32.32 
100ng 41.98 42.58 45.56 43.47 
1µg 54.14 51.16 49.37 59.51 
10µg 56.41 62.61 58.20 71.55 
100µg 59.09 66.31 62.08 73.46 
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Fig 1: MCF-7 cell line inhibition of various extracts in different concentrations. 
 
 
Fig 2: Graphical representation of MCF-7 cell line inhibition of various extracts. 
 
DISCUSSION 
Cancer is often associated with increased risk of death and the toxic side effects caused by the 
modern medicine, many cancer patients seek alternative and complementary methods of 
treatment such as usage of phyto medicine. 
 
The present study shows a dramatic in-vitro anticancer activity of various extracts of A. 
tetracantha on human breast cancer cell line (MCF-7) at increasing concentrations. It showed 
that the ethanolic extract have more anticancer activity on MCF-7 cell line in the ng range. 
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CONCLUSION 
The present study showed that Azima tetracantha, ethanolic leaf extract might be a potential 
alternative agent for human breast cancer therapy. Hence, it is anticipated that A. tetracantha 
would be a useful pharmaceutical material to treat breast cancer. Future research should focus 
on the molecular mechanism of A. tetracantha for anticancer action. There is a need for 
further investigation of this plant in order to identify and isolate its active anticancer 
principle(s) to treat breast cancer. 
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ABSTRACT 
 
The present study deals with evaluation of pharmacognostical characters of an important medicinal plant, Azima 
tetracantha Lam. The pharmacognostical studies were carried out such as organoleptic, macroscopic, 
microscopic and fluorescence analysis. Microscopic studies include transverse and longitudinal sections, powder 
microscopy and quantitative microscopy such as stomatal number, stomatal index, vein islet number and veinlet 
termination number. Various pharmacognostical characters observed in this study help in the identification and 
standardization of Azima tetracantha. 
 
Keywords: Azima tetracantha, Microscopy, Organoleptic, Fluorescence analysis, Identification. 
 
 
INTRODUCTION 
 
Over the last few decades, there has been a growing 
interest in drugs of plant origin in contrast to the 
synthetics that are regarded as unsafe to human and 
environment.1 Azima tetracantha Lam., is a unique 
folk medicinal plant known as Mulsangu in Tamil, 
belonging to the family “Salvadoraceae”, Azima 
tetracantha is a perennial shrub growing upto 3m 
height in hot, dry riverine scrub, particularly on 
alluvial or saline soil. It occurs naturally in central, 
eastern and southern Africa as well as in the Indian 
Ocean Islands and extends through Arabia to 
tropical Asia. It has various medicinal properties 
like stimulant, antispasmodic, anti-rheumatism, 
diuretic, anti-inflammatory, anti-microbial, 
hypoglycemic, antioxidant and hypolipidemic 
activity. It is also used in the treatment of cancer, 
dyspepsia and chronic diarrhoea.2,3 Microscopy is 
an important tool for authentication of crude drugs 
and study of powdered drugs.4 It is important to 
interpret morphological and anatomical 
descriptions of crude drugs as well as characteristic 
features of drugs and adulterants of commercial 
significance.5 Establishment of the 
pharmacognostic, morphological and microscopical 
characters of leaves and stem of the plant will assist 
in standardization, which can guarantee quality, 
purity and identification of samples. 
 
MATERIALS AND METHODS 
 
Procurement of plant materials: Fresh leaves and 
stem of Azima tetracantha were collected from 
Vellore district, Tamilnadu, India. Identification of 
the plant was done by Dr. G.V.S Murthy, Scientist 
‘F’, Botanical Survey of India, under reference 
number BSI/SRC/5/23/2016/Tech./178. 
 
Organoleptic evaluation6: Organoleptic 
evaluation can be done by means of sense organs, 
which provide the simplest as well as quickest 
means to establish the identity and purity to ensure 
quality of particular drug. Various sensory 
parameters of the plant material (such as colour, 
odour, size, shape, and taste) were studied by 
organoleptic evaluation. 
 
Macroscopic evaluation7: Various macroscopic 
characters of fresh leaves and stem of Azima 
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tetracantha were recorded such as type of leaf 
base, presence or absence of petiole and characters 
of lamina. Lamina consists of characteristic 
features such as composition, incision, shape, 
venation, margin, apex, base, surface and texture. 
The stem is morphologically studied for its size, 
shape, surface, fracture and configuration.6 
 
Microscopic evaluation: In microscopic 
evaluation, studies were conducted on both grounds 
qualitatively and quantitatively.  
 
Qualitative microscopy: In this study, transverse 
and longitudinal sections of leaf and stem were 
studied under photomicrograph. Staining reagents 
(such as phloroglucinol-HCl and methyl orange) 
were used as per standard procedures.8-11 The 
various identifying characters were studied with or 
without staining and recorded. 
 
Powder microscopy: The dried leaves and stem 
were powdered and studied under microscope. 
Different staining reagents (such as iodine for 
detection of starch grains and phloroglucinol for 
detection of lignified components) were used. A 
little quantity of leaves and stem powder were 
taken onto a microscopic slide, 1–2 drops of 0.1% 
w/v phloroglucinol solution and a drop of 
concentrated hydrochloric acid were added and 
covered with a cover slip. The slide preparation 
was mounted in glycerol and examined under 
microscope. The presence of starch grain and 
calcium oxalate crystal was detected by the 
formation of blue colour on addition of 2–3 drops 
of 0.01 M iodine solution.12 The characteristic 
structures and cell components were observed and 
their photographs were taken using 
photomicrography. 
 
Quantitative microscopy9,13 
Determination of stomatal number and stomatal 
index: Stomatal number is the average number of 
stomata per sq mm of epidermis of the leaf. The 
percentage proportion of the ultimate divisions of 
the epidermis of a leaf which can be converted into 
stomata is termed as stomatal index. Stomatal 
index can be calculated by using following 
equation: 
S. I = S / E + S×100 
Where, I = stomatal index, S = number of stomata 
per mm2 and E = number of ordinary epidermal 
cells per mm2.  
 
A piece of leaf was cleaned and the upper and 
lower epidermis was peeled out separately by 
means of forceps. It was kept on slide and mounted 
in glycerin water. Camera lucida was attached and 
drawing board was placed for drawing the cells. A 
square of 1 mm by means of stage micrometer was 
drawn on it. The slide with cleared leaf was placed 
on the stage and the epidermal cells and stomata 
were traced. The number of stomata and the 
number of epidermal cells in each field were 
counted. The numbers of stomata were counted as 
stomatal number and the stomatal index using the 
above formula was calculated separately for upper 
and lower surface. 
 
Determination of vein-islet and vein termination 
number: Vein islet is the minute area of 
photosynthetic tissue encircled by the ultimate 
division of the conducting strands. Vein 
termination number is the number of veinlet 
terminations per sq mm of leaf surface. 
  
A piece of the leaf was cleared by boiling in chloral 
hydrate solution and camera lucida and drawings 
board were arranged and 1 mm line was drawn 
with help of stage mm. A square was constructed 
on this line in the centre of the field. The slide was 
placed on the stage. The veins included within the 
square were traced off, completing the outline of 
those islets which overlap two adjustment side of 
the square. The average number of vein islet from 
the four adjoining square, to get the value for one 
square mm was calculated. The number of veinlet 
termination present within the square was counted 
and the average number of veinlet termination 
number from the four adjoining square to get the 
value for 1 sq mm was found known as vein 
termination number 
 
Physicochemical analysis14,15: Physicochemical 
constants such as ash values, extractive values, loss 
on drying, volatile oil content, swelling index, 
foaming index and foreign organic matter were 
observed 
 
Fluorescence analysis16: Fluorescence analysis of 
powder of leaves was done by standard procedure. 
In this analysis the powder were treated with 
various acidic and basic solvents and were then 
observed in UV/ visible chamber under visible, 
short wave and long wave regions simultaneously. 
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RESULTS 
Macroscopical characters
 
       A) Leaf 
 
      C) Stem with thorns 
 
B) Flowers 
   
 
D) Fruits
 
             
E) Length of leaf                                               F) Breadth of Leaf 
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Fig 1: Macroscopy of Azima tetracantha Lam. 
Morphology of Azima tetracantha A) Leaf, B) Stem with thorns, C) Flower, D) Fruits, E) Length of Leaf and F) 
Breadth of Leaf 
Organoleptic evaluation 
Table 1: Organoleptic evaluation of Azima tetracantha Lam. 
S. No Particulars Observations 
1. Colour  Dark green to pale green 
2. Odour Characteristic odour  
3. Taste Tasteless  
5. Margin Simple and entire  
6. Apex Mucronate, sharp-tipped  
7. Base Acute base  
9. Shape Aristate with a spine on tip  
10. Vein Cross venulate  
11. Stipules Absent or rudimentary 
12. Leaflets Pinnate  
 
Microscopic evaluation 
 
 
Fig 2: Transverse section Azima tetracantha Leaf 
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A      B 
Fig 3: Transverse section of Azima tetracantha A) Stem, B) Thorn 
 
Fig 4: Longitudinal section of Azima tetracantha Leaf 
 
            
A                                        B 
Fig 5: Longitudinal section of Azima tetracantha A) Stem, B) Thorn 
UE- Upper epidermis, La- Lamina, Pa- Palisade cells, Xy- Xylem, Ph- Phloem, MR- Midrib, LE- Lower epidermis, Sch- Sclerenchyma, 
LV- Lateral vein, AS- Airsac, VB- Vascular bundle, Pig- Pigments, HF- Hypodermal fibres, PF- Pericyclic fibres, Cu- Cuticle, Co- Cortex 
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Powder microscopy 
           
Parenchyma      B) Sclerenchyma 
 
           
Trichomes       D) Fibres 
          
1. Stomata      E) Crystal sheath 
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Xylem vessels 
Fig 6: Powder microscopy of Azima tetracantha Leaf powder 
  
       
Epidermis      B) Fibres 
       
Pigments      D) Xylem vessels 
Fig 7: Powder microscopy of Azima tetracantha Stem powder 
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Quantitative microscopy 
 Table 2: Quantitative microscopy of Azima tetracantha Leaf 
S. No Parameters Values 
1. Stomatal number- Lower epidermis 23-27 
2. Stomatal index- Lowder epidermis 19-20 
3. Vein islet number- Lowder epidermis 
 
9-15 
4. Veinlet termination number- Lowder epidermis 15-19 
 
 
Fig 8: Quantitative microscopy of Azima tetracantha Leaf 
Physicochemical analysis 
 
Table 3: Physicochemical constants of Azima tetracantha Leaf and Stem 
 
S. No Parameters Leaves Stem 
1. Total ash 7.45% 21.039% 
2. Acid insoluble ash 1.06% 0.493% 
3. Water soluble ash 6.98% 13.985% 
4. Sulphated ash 15.35% 18.84% 
5. Loss on drying 15.27% 11.95% 
6. Water soluble extractive value 1.593% 1.394% 
7. Ethanol soluble extractive value 1.197% 0.399% 
8. Foreign organic matter 3.6% No 
9. Volatile oil content 1.5%v/w No 
10. Swelling Index No No 
11. Foaming Index <100 <100 
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Flourescence analysis 
Table 3: Flourescence analysis of Azima tetracantha Lam. leaves 
Treatment Day light UV light 
254nm 365nm 
Powder  Pale-brownish green  Pale green  Brown  
Powder + 1N NaOH (aqueous)  Yellowish green  Pale yellow  White  
Powder + 1N NaOH (alcoholic)  Pale green  Brownish green  Brownish green  
Powder + 1N Hydrochloric acid  Pale green  Brown  Black  
Powder + 50% Sulphuric acid  Pale green  Bluish green  Pale green  
Powder + 50% Nitric acid  Green  Yellowish green  Black  
Powder + Picric acid  Dark yellow  Brown  Pale  brown  
Powder + Acetic acid  Pale green  Brownish green  Pale green  
Powder + Ferric chloride  Orange  Brown  Pale brown  
Powder +Con. Nitric acid  Brown  Brown  Black  
Powder + Nitric acid + Ammonia  Green  Green  Black  
 
DISCUSSION 
 
Macroscopic study showed that leaf shape- blade 
elliptical-oblong to ovate-oblong or orbicular, base- 
pinnately veined with one pair of lateral veins and 
leaf margin was simple and entire with 
characteristic odour. Young stem measuring 1.5mm 
thick. Its outline is smooth and even. The 
characteristic microscopic features of leaves were 
observed the presence of epidermis, stomata, 
lamina and stem consists of a distinct continuous 
epidermis, cortex, vascular cylinder and pith. The 
characteristic microscopy of leaf powder showed 
the presence of parenchyma, sclerenchyma, 
trichomes, fibers, stomata, crystal sheath and xylem 
vessels. The characteristic microscopy of stem 
powder showed the presence of epidermis, fibres, 
pigments and xylem vessels. Quantitative 
microscopy showed the presence of stomata in the 
lower epidermis. There was no fluorescence 
compound in the plant drug. 
 
CONCLUSION 
Standardization is an important tool for herbal 
drugs in order to establish their identity, purity, 
safety and quality. In order to standardize a drug, 
various macroscopic, microscopic, fluorescence 
analysis are done. Morphological and 
microscopical studies of the leaf will enable to 
identify the crude drug. The quantitative 
determination of some pharmacognostical 
parameters is useful for setting standards for crude 
drugs. Stomatal number, stomatal index, vein islet 
and vein termination value determination are 
equally important in the evaluation of crude drugs. 
These values help in the evaluation of purity of 
drugs. In conclusion, the parameters which are 
reported here can be considered as distinctive 
enough to identify and decide the authenticity of 
this drug in herbal industry/ trade and this can be 
included as microscopic standards in Indian Herbal 
Pharmacopeia.
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ABSTRACT 
Objective: To evaluate the antioxidant activity of the isolated fractions 
of crude ethanolic extract of Azima tetracantha. Methods: The crude 
ethanolic extract of Azima tetracantha leaves was subjected to 
chromatographic separation using column and thin layer 
chromatographic techniques. From the eluted fractions, F16, F27, F32, 
F36, F37, F38 and F45 fractions were screened for antioxidant activity 
using DPPH assay in invitro. Results: The extract yielded 7 
component fractions. From which, fraction 32 (F32) exhibited the most 
profound anti-oxidant activity.  
 
KEYWORDS: Azima tetracantha, Bioassay guided fractionation, 
Antioxidant, DPPH assay. 
 
INTRODUCTION 
Bioactivity guided isolation method is commonly employed in drug discovery research due to 
its effectiveness to directly link the analyzed extract and targeted compounds using 
fractionation procedure that followed with certain biological activity. In pharmacognosy, a 
typical protocol to isolate a pure chemical agent from natural origin is bioassay-guided 
fractionation, meaning step-by-step separation of extracted components based on differences 
in their physicochemical properties, and assessing the biological activity, followed by next 
round of separation and assaying.  
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Antioxidant is a molecule capable of slowing or preventing the oxidation of other molecules. 
Oxidation is a chemical reaction that transfers electron from a substance to an oxidizing 
agent. Oxidation reactions can produce free radicals, which start chain reactions that damage 
cells.
[1] 
As oxidative stress might be an important part of many human diseases, the use of 
antioxidants in pharmacology is intensively studied, particularly as treatments for stroke and 
neurodegenerative diseases. However, it is unknown whether oxidative stress is the cause or 
the consequence of disease. Antioxidants are widely used as ingredients in dietary 
supplements in the hope of maintaining health and preventing diseases such as cancer and 
coronary heart disease.
[2]
  
 
MATERIALS AND METHODS 
Preparation and extraction of the plant material  
Fresh leaves of Azima tetracantha plant were collected and authenticated by a taxonomist 
from Botanical Survey India, Coimbatore. Freshly harvested leaves were air- dried at room 
temperature for a period for 2 weeks. Dried materials were coarsely grounded and stored in 
an air- tight container. About 200g of dried powdered leaves were packed well in soxhlet 
apparatus and was subjected for hot extraction with ethanol (99.9%) at 18 hrs. The extract 
was filtered while hot and concentrated under Rotary vacuum evaporator in order to remove 
the solvent completely, dried and kept in a desiccator till further use. 
 
Isolation of the crude extract of Azima tetracantha leaves
[3, 4]
  
Column chromatography 
The crude extract of Azima tetracantha (8 g) was subjected to column chromatography to 
separate the extract into its component fractions. Silica gel 100-200 mesh was used as the 
stationary phase while varying solvent combinations of increasing polarity were used as the 
mobile phase. The column was prepared using silica gel (100- 200 mesh) with hexane. The 
crude extracts 8g was mixed with 16g of silica gel (1:2) separately (60-120 slurry) and loaded 
in the packed column. Elution of the extract was done with solvent systems of gradually 
increasing polarity using hexane, chloroform, and ethanol. The following ratios of solvent 
combinations were sequentially used in the elution process; Hexane: chloroform 100:0, 95:5, 
90:10, 80:20, 50:50, 20:80, and 10:90; chloroform: Ethanol 100:0, 95:5, 90:10, 80:20, 50:50, 
20:80, and 10:90; 0:100 The column flow rate was 1ml/min approximately 200 ml of 45 
fractions was collected. TLC was carried out simultaneously for each fraction with the 
suitable mobile phase. The spots were visualized either by exposing to iodine vapors and/or 
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UV light. The fractions showing the same Rf was combined together. Based on TLC profile 
15 major fractions was collected, saved and kept under air current to facilitate drying. The 
collected fractions were resulted in the Table 1.  
 
Thin layer chromatography
[5-7]
 
Thin layer chromatography is a technique used for the separation, identification and 
estimation of single or mixture of components present in the various extracts. It is a reliable 
technique in which solute undergoes distribution between two phases, stationary and mobile 
phase. TLC was carried out using 5 μl of 100 mg extract/ml solution on Merck TLC F254 by 
Hexane: Ethyl acetate (7:3) and Chloroform: Ethanol (5:5) mixture as eluents.  
f
distance travelled by the compound
distance travelled by the solvent front
R 
 
 
Invitro Antioxidant activity
 
DPPH assay
[8]
 
The effect of given samples on DPPH radical was estimated according to the procedure 
described by Von Gadow et al. (1997). Two ml of 6 ×10
-5
 M methonolic solution of DPPH 
were added to 50 µl of a methonolic solution (10 mg ml
-1
) of the sample. Absorbance 
measurements commenced immediately. The decrease of absorbance at 515 nm was 
continuously recorded in a spectrophotometer for 16 min at room temperature. Methanolic 
solutions of pure compound (Vitamin C) were tested at 1 mg/ml concentration. The 
scavenging effect (decrease of absorbance at 515 nm) was plotted against the time and the 
percentage of DPPH radical scavenging ability of the sample was calculated from the 
absorbance value at the end of 16 m in duration as follows. 
 
All determinations were performed in triplicate. The percentage inhibition of the DPPH 
radical by the samples was calculated according to the formula.
[9]
 
IP = [(AC(0)- AA(t)/ AC(0))] × 100 
 
Where AC(0) is the absorbance of the control at t = 0 min. 
AA(t) is the absorbance of the antioxidants at t = 16 min. 
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RESULTS AND DISCUSSION 
Table 1: Isolation of the crude extract of Azima tetracantha leaves. 
S. No Eluent Solvent ratio Fractions 
1. Hexane 100 F1 
2. Hexane: Chloroform 95:5 F2-F6 
3. Hexane: Chloroform 90:10 F7-F15 
4. Hexane: Chloroform 80:20 F16 
5. Hexane: Chloroform 50:50 F17-F26 
6. Hexane: Chloroform 20:80 F27 
7. Hexane: Chloroform 10:90 F28-F31 
8. Chloroform 100 F32 
9. Chloroform: Methanol 95:5 F33-F35 
10. Chloroform: Methanol 90:10 F36 
11. Chloroform: Methanol 80:20 F37 
12. Chloroform: Methanol 50:50 F38 
13. Chloroform: Methanol 20:80 F39, F40 
14. Chloroform: Methanol 10:90 F41-F44 
15. Methanol 100 F45 
 
Invitro Antioxidant activity
 
Invitro antioxidant activity of all the fractions were done using DPPH assay and resulted in 
Table 2. 
 
Table 2: DPPH Scavenging Effect of various fractions.  
Fractions 
Control Concentrations µg/ml 
 200 400 600 800 1000 
OD OD % OD % OD % OD % OD % 
Vit C 0.595 0.531 10.76 0.425 28.57 0.31 47.90 0.247 58.49 0.133 77.65 
F1 0.595 0.578 2.86 0.544 8.57 0.512 13.95 0.489 17.82 0.477 19.83 
F2 0.595 0.565 5.04 0.537 9.75 0.521 12.44 0.519 12.77 0.501 15.80 
F3 0.595 0.58 2.52 0.576 3.19 0.558 6.22 0.527 11.43 0.508 14.62 
F4 0.595 0.511 14.12 0.467 21.51 0.422 29.08 0.386 35.13 0.351 41.01 
F5 0.595 0.593 0.34 0.581 2.35 0.578 2.86 0.556 6.55 0.532 10.59 
F6 0.595 0.568 4.54 0.543 8.74 0.415 30.25 0.403 32.27 0.377 36.64 
F7 0.595 0.581 2.35 0.572 3.87 0.481 19.16 0.422 29.08 0.407 31.60 
F8 0.595 0.533 10.42 0.506 14.96 0.46 22.69 0.369 37.98 0.261 56.13 
F9 0.595 0.591 0.67 0.574 3.53 0.512 13.95 0.493 17.14 0.469 21.18 
F10 0.595 0.571 4.03 0.542 8.91 0.521 12.44 0.497 16.47 0.473 20.50 
F11 0.595 0.588 1.18 0.571 4.03 0.535 10.08 0.503 15.46 0.477 19.83 
F12 0.595 0.593 0.34 0.582 2.18 0.566 4.87 0.549 7.73 0.521 12.43 
F13 0.595 0.559 6.05 0.532 10.59 0.511 14.12 0.496 16.64 0.47 21.01 
F14 0.595 0.584 1.85 0.563 5.38 0.551 7.39 0.532 10.59 0.514 13.61 
F15 0.595 0.552 7.23 0.516 13.28 0.451 24.20 0.382 35.80 0.317 46.72 
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Fig 1: Percentage inhibition of Fraction 8 comparison with Standard. 
 
CONCLUSION 
Bioactivity guided isolation played an important role in the isolation of active compounds/ 
fractions from the natural products. In the present study, bioactivity guided isolation of 
various compounds/ fractions were isolated from the leaves of Azima tetracantha. From the 
entire isolated fraction, it is concluded that the fraction 8 showed 56.13% of antioxidant 
activity when compared to that of standard (Vitamin C) in DPPH assay. Based on the 
antioxidant activity, further studies are needed to identify the anticancer potential of the 
isolated fraction. 
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Preliminary phytochemical and anti-diabetic activity 
of Cassia sophera Linn 
 
Nandhini S, Geethalakshmi S, Selvam S, Radha R, Jerad Suresh A, 
Muthusamy P 
 
Abstract 
The medicinal plant Cassia sophera was analysed for screening of phytochemical and anti-diabetic 
activity. The objective of the present study was to investigate anti-diabetic activity of Cassia sophera 
bark, using Streptozocin induced diabetic rats as model. The biochemical study was carried out and the 
results shown that ethanolic extract of dose 400 mg/Kg has more effective against Streptozocin induced 
diabetic rats. We conclude from the present study that the ethanolic extract of bark of Cassia sophera 
may be beneficial in the management of diabetes. 
 
Keywords: Cassia sophera Linn. Poonaverie, Blood glucose, Anti-diabetic. 
 
Introduction 
Cassia sophera Linn. (Caesalpiniaceae) known as Poonaverie in Tamil, is an evergreen herb 
found in India and most tropical countries. It is common in waste lands, on roadsides and in 
the forests. The plant is used in the treatment of diabetes, hepatoprotective, asthma, psoriasis 
and in ringworm infections [1-4]. 
Diabetes is known as “diabetes mellitus” - where diabetes comes from the Greek word for 
siphon, which describes the excessive thirst and urination of this condition, and mellitus is 
the Latin word for honey, because diabetic urine is filled with sugar and is sweet. Diabetes is 
the common term for several metabolic disorders in which the body no longer produces 
insulin or uses the insulin it produces ineffectively. Insulin is a hormone that is needed to 
convert sugar, starches and other food into energy needed for daily life. The cause of 
diabetes continues to be a mystery, although both genetics and environmental factors such as 
obesity and lack of exercise appear to play roles [5-7]. 
 
Materials and Methods 
The fresh bark of Cassia sophera was collected from Kerala state and the plant specimen 
was authenticated by Dr. V. Chelladurai, Research Officer Botany, Survey of Medicinal 
Plants Unit, Tirunelveli. 
 
Preparation of Extracts 
The first step was the preparation of successive solvent extracts. The dried coarsely 
powdered sample of Cassia sophera (500g) was first extracted with petroleum ether (60 – 80 
°C) in Soxhlet apparatus and then with solvents of increasing polarity like chloroform, ethyl 
acetate and ethanol at 60 – 70 °C. Each extracts was concentrated using rotary vacuum 
evaporator. The percentage yield, colour and consistency of these extracts were recorded and 
preceded for further detailed phytochemical and pharmacological screening. 
 
Phytochemical studies [8-10] 
Phytochemical evaluation is used to determine the nature of phyto constituents present in the 
plant by using suitable chemical tests. It is essential to study the pharmacological activities of 
the plant. Therefore a complete investigation is required to characterize the phyto 
constituents qualitatively and quantitatively. 
 
Preliminary phytochemical screening 
The chemical tests for various phyto constituents in the dried powder and exracts of bark of 
Cassia sophera Linn. were carried out as described below. 
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Detection of Alkaloids 
Dragendorff’s reagent 
The substance was dissolved in 5ml of distilled water, to this 
5 ml of 2 M HCl was added until an acid reaction occurs, 
then 1ml of Dragendorff’s reagent was added and examined 
for an immediate formation of an orange red precipitate. 
 
Mayer’s reagent 
The substance was mixed with little amount of dil. HCl and 
Mayer’s reagent and examined for the formation of white 
precipitate. 
 
Wagner’s reagent 
The test solution was mixed with Wagner’s reagent and 
examined for the formation of reddish brown precipitate. 
 
Detection of Glycosides 
Borntrager’s test 
The powdered material was boiled with 1ml of sulphuric acid 
in a test tube for five minutes. Filtered while hot, cooled and 
shaken with equal volume of chloroform. The lower layer of 
solvent was separated and shaken with half of its volume of 
dil. Ammonia. A rose pink to red colour is produced in the 
ammoniacal layer. 
 
Modified Borntrager’s test 
The test material was boiled with 2ml of dil. Sulphuric acid. 
This was treated with 2ml of 5% aqueous ferric chloride 
solution (freshly prepared) for 5 minutes, and shaken with 
equal volume of chloroform. The lower layer of solvent was 
separated and shaken with half of its volume of dil. 
Ammonia. A rose pink to red colour is produced in the 
ammoniacal layer. 
 
Detection of Steroids and Triterpenoids 
Libermann Burchards test 
The powdered drug was treated with few drops of acetic 
anhydride, boiled and cooled. Conc. Sulphuric acid was 
added from the sides of the test tube, brown ring is formed at 
the junction of two layers and upper layer turns green which 
shows the presence of steroids and formation of deep red 
colour indicates the presence of triterpenoids. 
 
Salkowski test 
The extracts was treated with few drops of Conc. Sulphuric 
acid, red colour at lower layer indicates presence of steroids 
and formation of yellow coloured lower layer indicates 
presence of triterpenoids. 
 
Detection of Flavonoids 
Shinoda test 
To the solution of extract, few piece of magnesium turnings 
and conc. HCl was added dropwise, pink to crimson red, 
occasionally green to blue colour appear after few minutes 
indicates the presence of flavonoids. 
 
Alkaline reagent test 
To the test solution, few drops of sodium hydroxide solution 
was added. Intense yellow colour is formed which turns to 
colorless on addition of few drops of dilute acid indicate the 
presence of flavonoids. 
 
Detection of Carbohydrates 
Molisch’s test 
To the test solution few drops of alcoholic α- naphthol 
solution and few drops of con. sulphuric acid were added 
through the sides of the test tube, purple to violet colour ring 
appears at junction. 
 
Fehling’s test 
The test solution was mixed with Fehling’s A and B and 
heated and examined for the appearance of red coloration for 
the presence of reducing sugar. 
 
Detection of Phenols 
Ferric chloride test 
A small quantity of substance were dissolved with 2ml 
distilled water and a few drops of 10% aqueous ferric 
chloride solution was added and observed for the appearance 
of blue or green colour. 
 
Detection of Proteins 
Biuret test 
The sample was treated with 5-8 drops of 10%w/w copper 
sulphate solution, violet colour is formed. 
 
Detection of Tannins 
Lead acetate test 
The test solution was mixed with basic lead acetate solution 
and examined for the formation of a white precipitate. 
 
 Ferric chloride test 
A few drops of 5% aqueous ferric chloride solution was 
added to 2 ml of aqueous extract of the drug and examined 
for the appearance of bluish black colour. 
 
Detection of Saponins 
A drop of sodium bicarbonate solution was added to the 
sample and the mixture was shaken vigorously and left for 3 
minutes. Development of any honey comb like froth was 
examined. 
 
Detection of Gum and Mucilage 
Small quantities of test substances was dissolved in 5 to 
10ml of acetic anhydride by means of heat, cooled and add 
0.05ml of conc. Sulphuric acid; it is examined for the 
formation of bright purplish red colour. 
 
Detection of Fixed oils and Fats 
Small quantities of extracts were pressed between two filter 
papers. An oily stain on filter paper indicates the presence of 
fixed oils and fats. 
 
Quantitative Estimation of Phytoconstituents 
Glycosides Estimation [11] 
Materials 
Tincture 
Baljet reagent (freshly prepared) 
 
Preparation of tincture 
A 10% extract in 70% alcohol is prepared by shaking for 2 
hrs then filtered. 
 
Spectrophotometric Determination 
In the assay of tincture, 10ml of the 10% tincture (+0.8g 
powdered bark) are diluted during purification to 200ml, 
from which 10 ml (=0.04g powdered bark) are used in the 
assay, after being treated with 10 ml Baljet’s reagent, and 
diluted with 20ml of water(to a total of 40ml). measure the 
absorbance of the tincture at 495 nm. 
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Fluorescence Analysis [12] 
Fluorescence analysis was carried out in day light and in UV 
light. The bark powder and extracts were treated with 
different solvents and the fluorescence was observed in day 
light and in near and far UV light. 
 
In vitro Glucose Diffusion Inhibition Study [13] 
A simple model system was used to evaluate the effects of 
plant extracts on glucose movements in vitro. The model was 
adapted from a method described by Edwards et al., which 
involved the use of a sealed dialysis tube into which 15ml of 
a solution of glucose and sodium chloride (0.15 M) was 
introduced and the appearance of glucose in the external 
solution was measured. The model used in the present 
experiment consisted of a dialysis tube into which 1 ml of 50 
g/l plant extract in 1% CMC and 2ml of 0.15 M sodium 
chloride containing 0.22 M D- glucose was added. The 
dialysis tube was sealed at each end and placed in a 50ml 
centrifuge tube containing 45 ml of 0.15 M sodium chloride. 
The tubes were placed on an orbital shaker and kept at room 
temperature. The movement of glucose into the external 
solution was monitored at set time intervals. 
 
In vivo Anti-Diabetic Activity [14, 15] 
Healthy Wistar albino rats weighing about 150-230g were 
kept fasting overnight but allowed for access to water. The 
rats were injected intra peritoneally with Streptozocin 
dissolved in citrate buffer of pH 4.5 at a dose of 555 mg/Kg 
body weight. After 48 hours, rats with blood glucose level 
250 mg/dl were selected for the study. 
 
Treatment 
The animals were randomly divided into 5 groups of six 
animals each, after the induction of diabetes. 
Group 1: Non diabetic control rats received 1ml of 1% CMC 
orally once daily for 4 weeks. 
Group 2: Diabetic control rats received 1ml of 1% CMC 
orally once daily for 4 weeks. 
Group 3: Diabetic control rats given Ethanolic bark extracts 
(200 mg/Kg) of Cassia sophera Linn. Made fine suspension 
with 1 ml of 1% CMC once daily for 4 weeks. 
Group 4: Diabetic control rats given Ethanolic bark extracts 
(400 mg/Kg) of Cassia sophera Linn. Made fine suspension 
with 1 ml of 1% CMC once daily for 4 weeks. 
Group 5: Diabetic control rats given Glibenclamide 3 mg/Kg 
body weight made fine suspension with 1ml of 1% CMC 
once daily for 4 weeks. 
 
Biochemical analysis 
Blood samples were collected from the retro orbital plexus of 
the rats at the end of 0 hr, 3 hr, 5 hr, 7 hr, 24 hr (Acute study) 
and 1st, 2nd, 3rd and 4th week (chronic study), samples were 
analysed for blood glucose content by glucometer. 
 
Results 
 
Table 1: Percentage yield of Successive solvent extracts of the bark of Cassia sophera Linn. 
 
S. No Extracts Methods of Extraction Physical Nature Colour Yield (%w/w) 
1. Petroleum ether 
Soxhlet extraction 
Semisolid Green 4.5 
2. Chloroform Semisolid Green 3.8 
3. Ethyl acetate Semisolid Brownish Green 6.2 
4. Ethanol Solid Brownish Green 9.6 
 
Table 2: Qualitative phytochemical analysis of bark of Cassia sophera Linn. 
 
S. No Chemical Constituents Powder Drug Petroleum Ether Chloroform Ethyl acetate Ethanol 
1. Carbohydrate - - - - - 
2. Alkaloids - - - - - 
3. Steroids + + - - - 
4. Glycosides + - - + + 
5. Saponins - - - - - 
6. Flavonoids - - - - - 
7. Tannins + - - - + 
8. Phenolic compounds - - - - - 
9. Proteins - - - - - 
10. Amino acids - - - - - 
11. Gums and Mucilage + - - - + 
12. Terpenoids - - - - - 
13. Resins - - - - - 
14. Chlorogenic acid - - - - - 
15. Fats and Oils + + - - - 
 
Table 3: Fluorescence Analysis of powdered bark of Cassia sophera Linn. 
 
S. No Treatment Day light Short UV (254nm) Long UV (366nm) 
1. Powder Yellowish Green Pale Green Pale Green 
2. Powder + Water Pale Green Pale Green Pale Green 
3. Powder+ 1N HCl Pale Yellow Pale Yellow Pale Yellow 
4. Powder+ 1N H2SO4 Pale Yellow Pale Yellow Pale Yellow 
5. Powder+ HNO3 Red Red Red 
6. Powder+ Acetic acid Green Pale Green Pale Green 
7. Powder+ 1N NaOH Pale Yellow Pale Yellow Pale Yellow 
8. Powder+ Picric acid Yellow Yellow Yellow 
9. Powder+ 1N KOH Pale Yellow Pale Yellow Pale Yellow 
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10. Powder+ Acetone Yellowish Green Pale Green Pale Green 
11. Powder+ Ammonia Yellowish Brown Brown Brown 
12. Powder+ Iodine Brown Brown Brown 
13. Powder+ FeCl3 Green Green Green 
14. Powder+ Ethanol Pale Yellow Pale Yellow Pale Yellow 
 
Table 4: Fluorescence analysis of various extracts 
 
S. No Extracts Day light Short UV (254nm) Long UV (366nm) 
1. Petroleum Ether Dark Green Green Green 
2. Chloroform Green Green Green 
3. Ethyl acetate Brown Brown Brown 
4. Ethanol Greenish Brown Greenish Brown Greenish Brown 
 
Table 5: Quantitative estimation of phytoconstituents of Cassia sophera Linn. 
 
S. No Phytoconstituents Quantity (%w/w) 
1. Glycosides 11.2 
 
Table 6: In vitro anti-diabetic activity 
 
Extract 1 hour 3 hours 5 hours 24 hours 27 hours 
Control (Absence of extract) 172.3±0.3 204.73±0.8 268.93±0.2 291.03±2.5 319.43±1.9 
Petroleum Ether (50g/l) 157.65±1.3 189.95±2.2 251.25±1.3 280.65±2.3 302.35±0.3 
Chloroform (50g/l) 132.48±1.5 163.04±1.4 232.77±0.8 253.47±0.8 283.13±2.9
Ethyl acetate (50g/l) 105.76±3.2 134.19±2.9 204.49±3.3 218.99±2.4 248.55±2.0 
Ethanol (50g/l) 90.45±2.2 99.23±2.5 177.12±1.9 201.77±3.4 214.22±0.6 
Values are expressed as mean ±SD (n=3) 
In vivo anti-diabetic activity 
 
Table 7: Effects of ethanolic extracts of the bark of Cassia sophera Linn. on blood glucose level in streptozocin 
induced diabetic rats (mg/dl) – Acute study 
 
Group 0 Hr 1 Hr 3Hr 5 Hr 7 Hr 24 Hr 
Normal 83±1.3 93±1.6 102±1.2 112±1.8 99±1.1 101±1.9 
Diabetic control 372±0.4 374±1.1 385±0.2 390±1.5 407±1.8 431±2.1 
Diabetic+ Glibenclamide (3mg/Kg) 342±1.2 315±1.4 288±1.7 246±2.3 225±1.2 198±1.8 
Diabetic+ Ethanolic Extract (200mg) 352±2.1 348±2.2 332±2.1 276±1.3 252±1.6 232±1.6 
Diabetic+ Ethanolic Extract (400mg) 334±1.4 329±0.8 297±1.3 262±2.3 233±2.2 210±2.3 
One way Anova values are expressed as mean ±SD n=6 
*p<0.05 compared to diabetic control 
 
Table 8: Chronic study 
 
Group Initial 1st week 2nd week 3 rd week 4th week 
Normal 90±1.4 96±1.3 100±1.2 99±1.2 93±1.7 
Diabetic control 264±1.4 278±1.6 282±0.8 290±1.1 307±1.9 
Diabetic+ Glibenclamide (3mg/Kg) 250±0.9 248±0.5 200±1.3 182±1.3 148±1.2 
Diabetic+ Ethanolic Extract (200mg) 278±1.3 274±2.7 216±1.9 209±2.3 197±1.5 
Diabetic+ Ethanolic Extract (400mg) 270±1.2 261±2.3 206±1.5 191±2.5 173±1.6 
 
Discussion  
In the present study the preliminary phytochemical screening 
was carried out on Cassia sophera indicates the presence of 
steroids in petroleum ether and ethanol, glycosides in ethanol 
and tannins in ethanolic extract. The research has been 
carried out to evaluate the potential of various extracts to 
additionally retard the diffusion and movement of glucose in 
the intestinal tract. In vivo study showed that the 
administration of ethanolic bark extracts of Cassia sophera 
Linn. at the dose of 200mg/Kg and 400mg/Kg produced a 
significant reduction in blood glucose level. However, the 
ethanolic extract at the dose of 400mg/Kg was found to be 
more effective. It may be due to the presence of 
phytochemical constituents present in the plant. The results 
of the study strongly suggest that Cassia sophera Linn. Is 
useful in the treatment of diabetes. 
 
 
Conclusion 
From the overall study it is concluded that the ethanolic 
extract of Cassia sophera Linn. Is found to have anti-diabetic 
effect in Streptozocin induced diabetes in Wistar albino rats. 
Therefore, this treatment can safely be considered to be an 
alternative antihyperglycemic drug for diabetic patients. 
Further studies are warranted to isolate and characterise the 
anti-diabetic principles from the bark of Cassia sophera.  
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ABSTRACT 
Ziziphus oenoplia (L) Mill (Rhamnaceae) is a flowering plant with a broad distribution through 
tropical and subtropical Asia and Australia. It is a spreading, sometimes climbing, thorny shrub 
growing to 1.5m in height. The antibacterial activities of the hot and cold methanol extracts of the 
stem barks of Ziziphus oenoplia was evaluated on four bacterial strains like Staphylococcus 
aureus, Bacillus subtilis, Escherichia coli and Proteus vulgaris. The in-vitro antibacterial activity 
of hot and cold methanol extracts was performed by cup plate agar diffusion method. Ciprofloxacin  
(ciprozol-500) is used as a standard drug for the comparison of antibacterial activity. The hot 
methanol extract of Ziziphus oenoplia did produce considerable antibacterial activity than the cold 
maceration extract was observed. The maximum antibacterial activity of hot and cold methanol 
extracts was exhibited against Staphylococcus aureus when compared with standard drug. In 
addition the preliminary phytochemical screening of the hot and cold methanol extracts of Ziziphus 
oenoplia stem barks revealed the presence of alkaloids, carbohydrates, flavonoids, glycosides, 
saponins, tannins, and steroids. The results obtained in the present study suggest that Ziziphus 
oenoplia barks can be used in treating bacterial infections caused by the test organisms. Further 
studies on isolating chemical constituents of above extracts are necessary, in order to identify the 
active constituent responsible for the activity. 
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INTRODUCTION 
Medicinal plants are used in the treatment of infections caused by bacteria, fungi, viruses and 
parasites by the local population. Ziziphus oenoplia (L) Mill (Rhamnaceae) is a flowering plant 
with a wide distribution through tropical and subtropical Asia and Australia. It is a spreading, 
sometimes climbing, thorny shrub growing to 1.5m in height. Ziziphus species have been 
extensively used in indigenous system of medicine as folk remedy for various ailments like 
dysentery, inflammation, sore throats and digestive problems etc.1  
 
 
EXPERIMENTAL METHODS  
 
Plant Collection, Authentication and Extract Preparation 
 
The stem barks of Ziziphus oenoplia were collected from Koovathur village, Ariyalur, Tamil Nadu. 
The plant was authenticated by Dr. P. Jayaraman, Botanist, Plant Anatomy Research Centre 
(PARC), Chennai. The shade dried stem bark was powdered. The fine powder of the Ziziphus 
oenoplia stem bark was extracted with methanol at 48 h by hot continuous extraction and cold 
maceration method. The extracts were filtered and concentrated using a Rotary vacuum 
evaporator. The extracts were indicated as T1 & T2  respectively. 
 
Phytochemical Analysis2 
 
Both the hot and cold methanol extracts obtained from the powdered bark of the Ziziphus oenoplia 
were subjected to preliminary phytochemical investigation for alkaloids, carbohydrates, 
flavonoids, glycosides, lignin, saponins, terpenes, tannins, steroids and reducing sugar. The results 
are given in the Table1. 
 
Antibacterial Screening3 
 
The antimicrobial activity of the crude extracts were screened against gram positive bacteria and 
gram negative bacteria obtained from the laboratory stock of the Institute of Microbiology, Madras 
Medical College, Chennai, Tamil Nadu. The organisms that were tested are Staphylococcus 
aureus, Bacillus subtilis, Escherichia coli and Proteus vulgaris. 1ml of each bacterial strain was 
initially inoculated in 100 ml of sterile nutrient broth and incubated for 37°±1°C for 24 h (Working 
stock). The medium used was nutrient agar medium. 
 
The Antimicrobial assay was performed by cup plate agar diffusion method. 0.2ml of working 
stock from each organism was seeded into 100ml sterile nutrient agar medium in a sterile petri 
dish. After the agar solidified, four holes of uniform diameter (7mm) were made in the medium 
Sundaresan et. al.,                                                                        Volume 4 – Issue 3  
 
Vol: 4(3) February 2016 
    3 
                                         www.ijopils.com 
  
using a sterile borer. 0.2ml of varying concentrations (10-50 mg/ml) of T1, T2 and standard 
(Ciprofloxacin) and vehicle (DMSO) were placed in each hole for all the organisms under aseptic 
conditions. The plates were then maintained at room temperature for 2 h to allow the diffusion of 
the solution into the medium. All the bacterial plates were then incubated at 37°±1°C for 18 h and 
the zone of inhibition was measured. For each zone, an average of three independent measurements 
was determined. The values indicate the zone of inhibition in cm, including the diameter of the 
bore (7 mm). The results are given in Table 2.  
 
RESULTS AND DISCUSSION 
 
Table 1: Phytochemicals present in the hot and cold methanol extracts of Ziziphus oenoplia 
bark  
Secondary metabolites T1 T2 
Carbohydrates + + 
Flavonoids + + 
Glycosides + + 
Lignans - - 
Saponins + + 
Terpenes - - 
Tannins + - 
Steroids + + 
Reducing sugars + - 
Alkaloids + + 
       ‘+’ Present, ‘-’Absent  
 
The preliminary phytochemical studies revealed the presence of alkaloids, carbohydrates, 
flavonoids, glycosides, saponins, tannins, steroids and reducing sugar. 
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Table 2: Zone of inhibition of the hot and cold methanol extracts of Ziziphus oenoplia bark 
Extracts tested Concentratio
n (mg/ml) 
Diameter of the zone of inhibition in (cm) 
S. aureus B. subtilis E. coli P. vulgaris 
Hot methanol Extract (T1) 10 
20 
30 
40 
50 
2.0 
2.3 
3.0 
3.3 
3.7 
1.7 
1.9 
2.1 
2.4 
2.5 
1.7 
2.1 
2.2 
2.3 
2.6 
1.3 
1.3 
1.6 
1.8 
2.1 
Cold methanol Extract (T2 ) 
 
10 
20 
30 
40 
50 
2.0 
2.2 
2.4 
2.5 
2.9 
1.2 
1.4 
1.5 
1.8 
1.8 
1.5 
1.8 
1.9 
2.2 
2.3 
1.0 
1.2 
1.4 
1.5 
1.6 
Ciprofloxacin 
 
10 
20 
30 
40 
50 
3.7 
4.0 
3.9 
4.1 
4.2 
3.4 
3.5 
3.6 
3.7 
3.9 
3.1 
3.2 
3.4 
3.5 
3.6 
3.2 
3.3 
3.5 
3.6 
3.6 
 
From the table, it is seen that both the methanol extracts T1 & T2 showed good antibacterial activity 
against both gram positive & gram negative bacteria. Their activity is comparable with that of the 
standard drug ciprofloxacin, though the activity is lesser. Among the two extracts, the methanol 
extract prepared by hot extraction method showed better activity against all the four organisms 
tested. 
 
CONCLUSION  
 
From this study, we conclude that the methanolic extract of the bark of Ziziphus oenoplia has good 
antibacterial activity. The method of extraction also plays an important role in extracting the 
phytoconstituents. The results open up the possibility of finding new clinically effective anti-
bacterial compounds in an era where several microorganisms are to becoming resistant to 
conventional drugs.  
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